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 The intricate circuitry formed by amacrine cells in the inner plexiform layer (IPL) of the 
retina suggests that these interneurons play a major role in shaping the visual message.  The 
majority of amacrine cells in the vertebrate retina are GABAergic.  Thus, elucidating how 
GABAergic signaling is modulated in the IPL is critical in order to understand how the visual 
message is processed in the retina.  The results presented here suggest that GABAergic 
signaling between amacrine cells can be modulated by the activation of metabotropic 
glutamate receptor 5 (mGluR5) or by the production of the second messenger, nitric oxide 
(NO).  A novel mGluR5 splice variant was isolated from the chicken retina with a truncated 
carboxy-terminal tail.  Whole cell electrophysiological experiments indicated that activation 
of mGluR5 enhances GABA-gated currents recorded from cultured chick amacrine cells.  
This mGluR5-dependent enhancement occurred through the inositol 1,4,5-trisphosphate 
pathway and was dependent upon the release of Ca2+ from internal stores.  The Ca2+-
dependent protein kinase (PKC) was also required for the mGluR5-dependent enhancement as 
indicated by 1) enhancement of GABA-gated currents by PKC activators, 2) occlusion of the 
mGluR5-dependent enhancement by these activators, and 3) reduction of the mGluR5-
dependent enhancement by a PKC inhibitor.  The mGluR5-dependent enhancement of 
synaptic currents was nearly twice that observed for whole cell GABA-gated currents, 
suggesting that the receptors and signaling molecules are targeted to GABAergic synapses.  
NO also modulated GABAergic transmission between amacrine cells, but through two 
different pathways.  Lower concentrations of NO released from NO donors enhanced GABA-
gated currents by affecting the function of the GABAA receptors through a soluble guanylate 
cyclase-independent pathway.  Higher concentrations of NO (NO-bubbled solutions) 
 ix
 x
increased the intracellular Cl- concentration through an uncharacterized and potentially novel 
mechanism that possibly involves Cl- cotransporters.  The NO-induced influx of Cl- shifts the 
Cl- equilibrium potential (ECl-) to more positive values.  Furthermore, the NO-induced shift in 
ECl- allows GABA to depolarize the membrane potential, indicating that NO can convert an 
















 The precise circuitry of the vertebrate retina suggests that each cell type has a 
specialized role in the detection or processing of the visual signal.  The photon-activated 
second messenger cascade in photoreceptors converts light stimuli to neuronal responses that 
are then transmitted through glutamatergic ribbon-synapses onto bipolar cells.  The 
expression of either ionotropic glutamate receptors (iGluRs) or metabotropic glutamate 
receptors (mGluRs) by OFF or ON bipolar cells creates two parallel networks that transmit 
their signals through glutamatergic ribbon-synapses to the ganglion cells.  Although much of 
the visual message is translated at the subsequent visual centers of the brain, it is clear that 
significant processing occurs within the retina through the activity of lateral signaling 
networks.  In the outer retina, the inhibitory horizontal cells influence synaptic signaling at 
photoreceptor-bipolar cell synapses.  In the inner retina, the amacrine cells, the focus of this 
study, serve several roles and help shape the visual message before it leaves the retina.   
 Amacrine cells form synapses onto bipolar cells, ganglion cells, and other amacrine 
cells in the inner plexiform layer (IPL) of the retina (Dowling and Boycott 1965; Dubin 1970; 
Hartveit 1999).  Advances in imaging technology have aided in the structural classification of 
amacrine cells, with approximately 30 morphological classes identified in the mammalian 
retina (MacNeil and Masland 1998; MacNeil et al. 1999).  Amacrine cells can also be 
classified based upon transmitter expression.  Although these cells are known to express 
several different neurotransmitters (acetylcholine, glutamate, dopamine, serotonin), the vast 
majority of amacrine cells are inhibitory and express either GABA or glycine.  However, it is 
generally accepted that GABA is the predominant neurotransmitter expressed by amacrine 
cells.  Support for this claim was recently demonstrated in goldfish where over 90% of the 
non-ribbon synapses in the IPL are GABAergic (Marc and Liu 2000).   
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Although much is known of the general anatomy and synaptic architecture of the 
retina, an emerging and challenging frontier in the field of retinal neuroscience is 
understanding how retinal synapses are modulated.  Given the diversity of presynaptic inputs 
from other amacrine cells and the glutamatergic inputs from bipolar cells, amacrine cells are 
likely targets for modulation.  The expression of several 2nd messenger-linked receptors has 
been demonstrated for amacrine cells including dopamine receptors (Stormann et al. 1990; 
Derouiche and Asan 1999; Koulen 1999), metabotropic GABAB receptors (Matthews et al. 
1994; Tian and Slaughter 1994; Catsicas and Mobbs 2001), and mGluRs (Koulen et al. 1997; 
Cai and Pourcho 1999; Kreimborg et al. 2001).  Thus, there is great potential for regulating 
signal processing in the IPL.  However, little is currently known about the modulatory 
mechanisms that might affect amacrine cell signaling in the IPL.    
The focus of the present study is to gain some understanding of how GABAergic 
transmission between retinal amacrine cells is modulated.  To address this question at the 
cellular and molecular level would be extremely difficult in the intact retina given the 
complex circuitry, the diversity of pre- and post-synaptic partners, and the impracticality of 
electrically isolating individual amacrine cells.  Therefore, in order to study modulation of 
amacrine cell signaling at the cellular level, this study utilizes cultures of previously described 
GABAergic amacrine cells from the chick retina (Gleason et al. 1993).  Although cultured 
from embryonic retinae, the functional development of these cultured amacrine cells closely 
matches that of amacrine cells found in the intact retina (Huba and Hofmann 1991; Huba et al. 
1992).  Currents can be recorded from activated ligand-gated (GABAA, NMDA, non-NMDA, 
glycine, and acetylcholine) and voltage-gated (Na+, Ca2+, and K+) ion channels at embryonic 
equivalent day 14 (EE 14).  Furthermore, functional synapses between pairs of cells and 
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synapses onto the same cells (autapses) form as early as EE 16 (Gleason et al. 1994; Frerking 
et al. 1995), a time when synaptic activity is detected in the IPL of the embryonic chick (Grün 
1982).  Given the relative ease of their preparation and the accessibility for electrophysiology 
experiments, these cultures provide an ideal model system for studying GABAergic signaling 
in amacrine cells. 
The results presented here are focused on the modulation of signaling between 
GABAergic amacrine cells by activation of mGluR5 and the gaseous second messenger, nitric 
oxide (NO).  Previous studies have shown that amacrine cells in the intact chicken retina and 
in culture express mGluR5 (Kreimborg et al. 2001).  Ca2+-imaging studies have demonstrated 
that these receptors are functionally coupled to the IP3 pathway.  The results presented here 
describe a novel mGluR5 splice variant isolated from adult chicken retina.  This study also 
demonstrates that activation of mGluR5 enhances GABA-gated currents, and the Ca-
dependent protein kinase (PKC) is involved in this enhancement.  Immunolabeling studies 
have also shown that the synthetic enzyme, brain nitric oxide synthase, is expressed by 
amacrine cells in the chicken retina (Fischer and Stell 1999; Crousillac et al. 2003).  Evidence 
presented here demonstrates that NO can enhance GABA-gated currents and shift the chloride 
reversal potential through an uncharacterized, and potentially novel, mechanisms that may 
involve Cl- cotransporters.  Together, these results suggest that multiple pathways can be 
activated in GABAergic amacrine cells and it seems likely that this can have a profound effect 
on retinal processing in the IPL of the retina.   
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Metabotropic glutamate receptors comprise a family of G protein-coupled receptors 
that are implicated in multiple signal transduction pathways.  Since the cloning and 
expression of the first mGluR subtype (Houamed et al. 1991; Masu et al. 1991), the family 
has expanded to eight members that are segregated into 3 groups based on amino acid 
sequence similarity, signal transduction pathways, and pharmacological properties.  Within 
groups, mGluRs share about 70% sequence similarity, whereas between-group homology 
averages about 45% (Nakanishi 1992).  Group I consists of mGluRs 1 and 5 and typically 
signals through the IP3 signaling pathway.  Group II includes mGluRs 2 and 3, and group III 
includes mGluRs 4,6,7, and 8.  Both of these groups are negatively coupled to adenylate 
cyclase.   
In the chicken retina, immunocytochemistry studies revealed that both of the group I 
mGluRs are expressed (Kreimborg et al. 2001).  Although, the canonical signaling pathway 
associated with group I mGluRs is the IP3 pathway, there is also evidence that activation of 
the group I mGluRs can lead to increases adenylate cyclase activity, suggesting that these 
receptors can also couple to the G protein, Gs (Joly et al. 1995).  Although this ability to 
couple to multiple G proteins increases the diversity of signaling pathways utilized by a single 
receptor, it also complicates any predictions of glutamate’s role in the inner retina.   
 The goal of the present study was to obtain group I mGluR sequence data from 
mRNA isolated from the chicken retina.  At the beginning of this work, no chicken-specific 
sequence data were available for the group I mGluRs.  To obtain these data, we utilized a RT-
PCR approach to amplify mGluR5 message from chicken mRNA expressed in the retina.  Our 
efforts uncovered a previously unidentified splice-variant of chicken mGluR5, mGluR5h.  
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This splice variant has a short carboxy-terminal, similar to another group I mGluR splice 
variant, mGluR1c.  Sequence comparisons of this novel mGluR5 splice variant with other 
published sequences of full-length mGluR5 clones from several species suggest that chicken 
mGluR5 can couple to either Gq or Gs.   
METHODS 
Retinal tissue was obtained from White Leghorn chickens (Gallus gallus domesticus) 
from the Poultry Science Department, Louisiana State University.  Chickens were killed by 
cervical dislocation and decapitation.  All methods employing live animals were approved by 
the Louisiana State University Institutional Animal Care and Use Committee in accordance 
with National Institutes of Health guidelines.  Retinas were removed and RNA was isolated 
with RNAzol (Tel.Test Inc, Friendswood, TX, USA) following the manufacturer’s protocol.  
To ensure that all genomic DNA was removed, the samples were treated with DNAse I 
(Roche Molecular Biochemicals, Mannheim, Germany) prior to the RT reactions.  Negative 
controls without reverse transcriptase confirmed that genomic DNA was not a source of PCR 
products. 
 The initial RT-PCR protocol and primers were designed to amplify and identify 
mGluR sequences between transmembrane segments II and V, as previously described 
(Medler et al. 1998).  The gel-purified PCR product was cloned into the pCR 2.1-TOPO 
vector (Invitrogen Corperation, Carlsbad, CA) and sequenced using an ABI Prism 377 DNA 
sequencer using Big Dye Terminator Chemistry (Applied Biosystems, Foster City, CA, 
USA).  The sequences were analyzed and compared with previously published mGluR 
sequences using BLAST.  Gene Runner software (Hastings Software, Hasting, NY, USA) was 
used to obtain the predicted amino acid sequences. 
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 To obtain sequence data downstream of transmembrane segment V, specific primers 
were designed for use with the 3’ Race System (Gibco, Rockville, MD, USA).  First-strand 
cDNA synthesis was performed with the supplied adapter primer (oligo dT) according to the 
manufacturer’s protocol.  Primers for the second-strand cDNA synthesis included the 
abridged universal amplification primer (AUAP) provided and a gene-specific primer (GSP) 
5’-GAGGTCTACTTGATTTGTAACACCACC.  The GSP-primed PCR was initiated at 94°C 
with Failsafe Enzyme Mix (Epicentre Technologies, Madison, WI, USA) and amplified 
according to the following schedule: 94°C for 1 min, 60°C for 1 min, 72°C for 3 min, for 35 
cycles followed by 72°C for 10 min.  A 1:100 dilution of the resulting product was used as the 
template for the amplification with a nested primer, 5’-
CTTGGATACAATGGATTATTAATATTGAG and the AUAP.  The nested PCR was 
initiated at 94°C and amplified according to the following schedule: 94°C for 1 min, 55.2°C 
for 1 min, 72°C for 3 min, for 35 cycles followed by 72°C for 10 min.  Identification of the 
amplification products was performed as described above.  
RESULTS 
Because no mGluR5 splice variants have been described with splice sites upstream of 
the seventh transmembrane domain, RT-PCR protocols and primers were designed to amplify 
the sequence of mGluR5 mRNA including, and downstream from, the region encoding 
transmembrane segment II.  The initial RT-PCR reactions were performed with degenerate 
primers corresponding to the transmembrane segments II and V.  Sequence analysis revealed 
that mRNAs corresponding to mGluRs 1, 2, 3, and 5 were each expressed in the retina.  This 
finding was not surprising, given the previously reported expression of all mGluR subtypes in 
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the adult retinas of several species (Hartveit et al. 1995; Koulen et al. 1997; Tehrani et al. 
2000; Kreimborg et al. 2001; Gerber 2003).   
Subsequent RT-PCR procedures utilizing chicken-specific primers and poly-dT 
primers were performed to amplify mGluR5 message downstream from transmembrane 
segment 5.  A novel splice variant for chicken mGluR5 was isolated and will be named 
mGluR5h (accession number AY078349).  Complete sequence analysis revealed a coding 
region encompassing 822 nucleotides.  The first 795 nucleotides were nearly identical (99.4 % 
sequence similarity) with sequences for chicken mGluR5 subtypes a, b, and f (accession 
numbers: AF227201, AF227203, AF227203) between nucleotide numbers 1855 and 2648 
(Figure 2.1).  Differences at the 5’ end are most likely attributable to the use of degenerate 
primers during the initial RT-PCR reactions.  Between the primer binding site and the final 28 
nucleotides, there was only one nucleotide in mGluR5h (A417) that did not match the other 
chicken mGluR5 subtypes.  However, the result of this single transversion event would be a 
null mutation with no change in the predicted amino acid sequence (Figure 2.2).    
The final 28 nucleotides of mGluR5h show no significant sequence identity with the 
other splice variants.  This insertion at the splice site introduces an in-frame stop codon.  The 
expected coding region for this sequence represents the shortest chicken mGluR5 splice 
variant by 795 nucleotides as compared to mGluR5a, the second shortest mGluR5 splice 
variant.  The predicted protein product for mGluR5h would be a truncated receptor with a C-
terminal tail of only 58 amino acids, with the final 7 residues showing no sequence similarity 
with the other splice variants (Figure 2.2). 
It was previously shown that the intracellular loops 2 and 3 of rat mGluR1 and 









Figure 2.1  The alignment of partial nucleotide sequences for chicken metabotropic 
glutamate receptor 5 (mGluR5) splice variants.  The nucleotide sequences for previously 
described chicken mGluR5 splice variants, subtypes a, b, and f (Accession numbers: 
AF227201, AF227203, AF227203), are aligned with mGluR5h.  The numbers at the right 
denote the position of the nucleotide number, number 1 corresponding to the 1st base of the 
coding sequence.  The first 1854 nucleotides and the final 783 nucleotides of the coding 
regions of the mGlur5 subtypes a, b, and f have been omitted.  No mRNA splice variants have 
been described upstream or downstream of the shown sequence for chicken mGluR5.  The 5’ 
and 3’ degenerate primer sites are indicated by bold text with a double underline.  The four 
sequence-specific primer sites are bold with a single underline.  Asterisks denote differences 
with the previously published mGluR5 subtypes.  The shaded boxes outline the nucleic acid 
sequences that encode amino acids in the putative transmembrane domains (TMDs 2-7). 
 12
                                                   TMD 2 
mGluR5a  TCCAGCCGAGAACTTTGCTACATCATTCTAGCTGGCATCTGCTTGGGTTACTTGTGCACTTTCTGTCTCATCGCAAAACCTCAACAGATT 1944 
mGluR5b  TCCAGCCGAGAACTTTGCTACATCATTCTAGCTGGCATCTGCTTGGGTTACTTGTGCACTTTCTGTCTCATCGCAAAACCTCAACAGATT 1944  
mGluR5f  TCCAGCCGAGAACTTTGCTACATCATTCTAGCTGGCATCTGCTTGGGTTACTTGTGCACTTTCTGTCTCATCGCAAAACCTCAACAGATT 1944  
mGluR5h  TCGAGGCGGGAACTGTGTTACATCATTCTAGCTGGCATCTGCTTGGGTTACTTGTGCACTTTCTGTCTCATCGCAAAACCTCAACAGATT 90  
              *  *     *  * 
       
mGluR5a  TACTGCTATCTTCAACGAATTGGCATCGGTCTCTCCCCAGCTATGAGTTATTCTGCTCTAGTAACTAAAACCAACCGCATTGCAAGAATC 2034  
                                TMD 3 
mGluR5b  TACTGCTATCTTCAACGAATTGGCATCGGTCTCTCCCCAGCTATGAGTTATTCTGCTCTAGTAACTAAAACCAACCGCATTGCAAGAATC 2034  
mGluR5f  TACTGCTATCTTCAACGAATTGGCATCGGTCTCTCCCCAGCTATGAGTTATTCTGCTCTAGTAACTAAAACCAACCGCATTGCAAGAATC 2034  
mGluR5h  TACTGCTATCTTCAACGAATTGGCATCGGTCTCTCCCCAGCTATGAGTTATTCTGCTCTAGTAACTAAAACCAACCGCATTGCAAGAATC 180  
 
       
mGluR5a  CTGGCTGGCAGCAAGAAGAAAATTTGTACAAAGAAACCTAGATTCATGAGTGCCTGTGCCCAACTTGTTATTGCATTTATCTTGATATGT 2124  
                                                                            TMD 4 
mGluR5b  CTGGCTGGCAGCAAGAAGAAAATTTGTACAAAGAAACCTAGATTCATGAGTGCCTGTGCCCAACTTGTTATTGCATTTATCTTGATATGT 2124  
mGluR5f  CTGGCTGGCAGCAAGAAGAAAATTTGTACAAAGAAACCTAGATTCATGAGTGCCTGTGCCCAACTTGTTATTGCATTTATCTTGATATGT 2124  
mGluR5h  CTGGCTGGCAGCAAGAAGAAAATTTGTACAAAGAAACCTAGATTCATGAGTGCCTGTGCCCAACTTGTTATTGCATTTATCTTGATATGT 270  
 
                      
mGluR5a  ATACAATTAGGCATAATTGTGGCCCTCTTTATAATGGAGCCACCTGATATAATGCATGATTACCCAAGCATCCGAGAGGTCTACTTGATT 2214  
mGluR5b  ATACAATTAGGCATAATTGTGGCCCTCTTTATAATGGAGCCACCTGATATAATGCATGATTACCCAAGCATCCGAGAGGTCTACTTGATT 2214  
mGluR5f  ATACAATTAGGCATAATTGTGGCCCTCTTTATAATGGAGCCACCTGATATAATGCATGATTACCCAAGCATCCGAGAGGTCTACTTGATT 2214  
mGluR5h  ATACAATTAGGCATAATTGTGGCCCTCTTTATAATGGAGCCACCTGATATAATGCATGATTACCCAAGCATCCGAGAGGTCTACTTGATT 360  
 
       
mGluR5a  TGTAACACCACCAACTTGGGTGTTGTAACCCCCCTTGGATACAATGGATTATTAATTTTGAGTTGCACCTTTTATGCATTTAAGACAAGA 2304  
                                              TMD 5 
mGluR5b  TGTAACACCACCAACTTGGGTGTTGTAACCCCCCTTGGATACAATGGATTATTAATTTTGAGTTGCACCTTTTATGCATTTAAGACAAGA 2304  
mGluR5f  TGTAACACCACCAACTTGGGTGTTGTAACCCCCCTTGGATACAATGGATTATTAATTTTGAGTTGCACCTTTTATGCATTTAAGACAAGA 2304  
mGluR5h  TGTAACACCACCAACTTGGGTGTTGTAACCCCCCTTGGATACAATGGATTATTAATATTGAGTTGCACCTTTTATGCATTTAAGACAAGA 450  
                                                                 * 
       
mGluR5a  AATGTCCCAGCTAATTTCAATGAAGCAAAGTATATTGCCTTTACAATGTATACCACCTGCATCATTTGGCTGGCTTTTGTGCCAATATAT 2394  
                                                                  TMD 6 
mGluR5b  AATGTCCCAGCTAATTTCAATGAAGCAAAGTATATTGCCTTTACAATGTATACCACCTGCATCATTTGGCTGGCTTTTGTGCCAATATAT 2394  
mGluR5f  AATGTCCCAGCTAATTTCAATGAAGCAAAGTATATTGCCTTTACAATGTATACCACCTGCATCATTTGGCTGGCTTTTGTGCCAATATAT 2394  
mGluR5h  AATGTCCCAGCTAATTTCAATGAAGCAAAGTATATTGCCTTTACAATGTATACCACCTGCATCATTTGGCTGGCTTTTGTGCCAATATAT 540  
 
       
mGluR5a  TTTGGAAGCAACTACAAGATAATCACCATGTGTTTCTCAGTGAGTCTGAGTGCCACGGTGGCCCTTGGTTGTATGTTTGTGCCCAAGGTC 2484  
                                                                  TMD 7 
mGluR5b  TTTGGAAGCAACTACAAGATAATCACCATGTGTTTCTCAGTGAGTCTGAGTGCCACGGTGGCCCTTGGTTGTATGTTTGTGCCCAAGGTC 2484  
mGluR5f  TTTGGAAGCAACTACAAGATAATCACCATGTGTTTCTCAGTGAGTCTGAGTGCCACGGTGGCCCTTGGTTGTATGTTTGTGCCCAAGGTC 2484  
mGluR5h  TTTGGAAGCAACTACAAGATAATCACCATGTGTTTCTCAGTGAGTCTGAGTGCCACGGTGGCCCTTGGTTGTATGTTTGTGCCCAAGGTC 630  
 
 
mGluR5a  TACATCATCCTTGCTAAGCCTGAAAGGAACGTACGCAGCGCATTCACCACTTCGACTGTGGTCCGCATGCATGTAGGGGATGGAAAATCA 2574  
mGluR5b  TACATCATCCTTGCTAAGCCTGAAAGGAACGTACGCAGCGCATTCACCACTTCGACTGTGGTCCGCATGCATGTAGGGGATGGAAAATCA 2574  
mGluR5f  TACATCATCCTTGCTAAGCCTGAAAGGAACGTACGCAGCGCATTCACCACTTCGACTGTGGTCCGCATGCATGTAGGGGATGGAAAATCA 2574  
mGluR5h  TACATCATCCTTGCTAAGCCTGAAAGGAACGTACGCAGCGCATTCACCACTTCGACTGTGGTCCGCATGCATGTAGGGGATGGAAAATCA 720  
 
 
mGluR5a  TCTTCGGCTGCGAGCCGCTCAAGCAGCCTGGTGAACCTGTGGAAAAGAAGGGGATCATCTGGTGAAACACTTAG---------------- 2648  
mGluR5b  TCTTCGGCTGCGAGCCGCTCAAGCAGCCTGGTGAACCTGTGGAAAAGAAGGGGATCATCTGGTGAAACACTTAG---------------- 2648  
mGluR5f  TCTTCGGCTGCGAGCCGCTCAAGCAGCCTGGTGAACCTGTGGAAAAGAAGGGGATCATCTGGTGAAACACTTAG---------------- 2648  
mGluR5h  TCTTCGGCTGCGAGCCGCTCAAGCAGCCTGGTGAACCTGTGGAAAAGAAGGGGATCATCTGGTGAAACACTTAGGTCTCGTCCACCAACT 810  
                                                                                   **************** 
 
mGluR5a  ------------------------------------------------------------------------------------------ 2648  
mGluR5b  ------------GTACAAAGGCAGGAGACTGGCCCCGCACAAGTCGGAAATAGAGTGTTTCACCCCAAAAGGGAGTATGGGGAATGGTGG 2726  
mGluR5f  ------------GTACAAAGGCAGGAGACTGGCCCCGCACAAGTCGGAAATAGAGTGTTTCACCCCAAAAGGGAGTATGGGGAATGGTGG 2726  
mGluR5h  TCCTCTAGTTAG                                                                               822  
 
 
        ************ 
mGluR5a  ------------------------------------------------------------------------------------------ 2648  
mGluR5b  GAGAGCTACAATGACCAG------------------------------------------------------------------------ 2744  
mGluR5f  GAGAGCTACAATGACCAGTGAAGAATCTGTTTGCATTCCAGAATGTAATCGATCTGAGTCAAGTAGAGATGAGAAAGAGGTTCCCGTTAA 2816  
mGluR5h                                                                                             822  
 
 
mGluR5a  ------------------------------------------------------------------------------------------ 2648  
mGluR5b  ------------------------------------------------------------------------------------------ 2744  
mGluR5f  AGAGGATGCCCTAACAGGCAAAAAGACTGGAAACTGTGTCAGTCTAATAGTGCCACAGCAAGACTGTCAGCTGCAAGACCTACTCAAACA 2906  
mGluR5h                                                                                             822  
 
 
mGluR5a  CTCTAATGGGAAATCAGTTTCCTGGGCCCAGAATGAGAAAAGCAGCAGAGGAGCGCACCTTTGGCAGCGGTTGTCAATCCACATCAACAA 2688  
mGluR5b  CTCTAATGGGAAATCAGTTTCCTGGGCCCAGAATGAGAAAAGCAGCAGAGGAGCGCACCTTTGGCAGCGGTTGTCAATCCACATCAACAA 2744  
mGluR5f  CTCTAATGGGAAATCAGTTTCCTGGGCCCAGAATGAGAAAAGCAGCAGAGGAGCGCACCTTTGGCAGCGGTTGTCAATCCACATCAACAA 2946  










                   TMD 2                                                  TMD 3 
chk5a  SSRELCYIILAGICLGYLCTFCLIAKPQQIYCYLQRIGIGLSPAMSYSALVTKTNRIARILAGSKKKICTKKPRFMSACA 698  
chk5b  SSRELCYIILAGICLGYLCTFCLIAKPQQIYCYLQRIGIGLSPAMSYSALVTKTNRIARILAGSKKKICTKKPRFMSACA 698  
chk5f  SSRELCYIILAGICLGYLCTFCLIAKPQQIYCYLQRIGIGLSPAMSYSALVTKTNRIARILAGSKKKICTKKPRFMSACA 698  
chk5h  SRRELCYIILAGICLGYLCTFCLIAKPQQIYCYLQRIGIGLSPAMSYSALVTKTNRIARILAGSKKKICTKKPRFMSACA 80   
        * 
                                     TMD 4                                                                                               TMD 5 
chk5a  QLVIAFILICIQLGIIVALFIMEPPDIMHDYPSIREVYLICNTTNLGVVTPLGYNGLLILSCTFYAFKTRNVPANFNEAK 778  
chk5b  QLVIAFILICIQLGIIVALFIMEPPDIMHDYPSIREVYLICNTTNLGVVTPLGYNGLLILSCTFYAFKTRNVPANFNEAK 778  
chk5f  QLVIAFILICIQLGIIVALFIMEPPDIMHDYPSIREVYLICNTTNLGVVTPLGYNGLLILSCTFYAFKTRNVPANFNEAK 778  
chk5h  QLVIAFILICIQLGIIVALFIMEPPDIMHDYPSIREVYLICNTTNLGVVTPLGYNGLLILSCTFYAFKTRNVPANFNEAK 160  
 
                                     TMD 6                                                               TMD 7 
chk5a  YIAFTMYTTCIIWLAFVPIYFGSNYKIITMCFSVSLSATVALGCMFVPKVYIILAKPERNVRSAFTTSTVVRMHVGDGKS 858  
chk5b  YIAFTMYTTCIIWLAFVPIYFGSNYKIITMCFSVSLSATVALGCMFVPKVYIILAKPERNVRSAFTTSTVVRMHVGDGKS 858  
chk5f  YIAFTMYTTCIIWLAFVPIYFGSNYKIITMCFSVSLSATVALGCMFVPKVYIILAKPERNVRSAFTTSTVVRMHVGDGKS 858  
chk5h  YIAFTMYTTCIIWLAFVPIYFGSNYKIITMCFSVSLSATVALGCMFVPKVYIILAKPERNVRSAFTTSTVVRMHVGDGKS 240  
 
 
chk5a  SSAASRSSSLVNLWKRRGSSGETLS------------------------------------------------------- 883  
chk5b  SSAASRSSSLVNLWKRRGSSGETLR-------YKGRRLAPHKSEIECFTPKGSMGNGGRATMTS---------------- 915  
chk5f  SSAASRSSSLVNLWKRRGSSGETLR-------YKGRRLAPHKSEIECFTPKGSMGNGGRATMTSEESVCIPECNRSESSR 931  
chk5h  SSAASRSSSLVNLWKRRGSSGETLSRPPTSSS                                                 272  
                                ******* 
 
chk5a  --------------------------------------SNGKSVSWAQNEKSSRGAHLWQRLSIHINKKENPNQTAVIKP 925  
chk5b  --------------------------------------SNGKSVSWAQNEKSSRGAHLWQRLSIHINKKENPNQTAVIKP 957  
chk5f  DEKEVPVKEDALTGKKTGNCVSLIVPQQDCQLQDLLKHSNGKSVSWAQNEKSSRGAHLWQRLSIHINKKENPNQTAVIKP 1012  
chk5h                                                                                   272  
 
 
chk5a  FSKSTDSSRHSSSATFPETSAKTLYDVSEAEEQYPAQYRPQTPSPISTVSHRTASVSRTEDDAPTFQSEPPQRSSSSQGS 1005  
chk5b  FSKSTDSSRHSSSATFPETSAKTLYDVSEAEEQYPAQYRPQTPSPISTVSHRTASVSRTEDDAPTFQSEPPQRSSSSQGS 1037  
chk5f  FSKSTDSSRHSSSATFPETSAKTLYDVSEAEEQYPAQYRPQTPSPISTVSHRTASVSRTEDDAPTFQSEPPQRSSSSQGS 1091 
chk5h                                                                                   272  
 
 
chk5a  LMEQISSVVTRFTANISELNSMMLSTATPGTMVATPLCSSYLIPREIQLPTTMTTFAEIQPLPSIEVNGASQSARKQSNG 1085  
chk5b  LMEQISSVVTRFTANISELNSMMLSTATPGTMVATPLCSSYLIPREIQLPTTMTTFAEIQPLPSIEVNGASQSARKQSNG 1117  
chk5f  LMEQISSVVTRFTANISELNSMMLSTATPGTMVATPLCSSYLIPREIQLPTTMTTFAEIQPLPSIEVNGASQSARKQSNG 1171  
chk5h                                                                                   272  
 
 
chk5a  SVKEGTAETPSAKQDLEELVALTPPSPFRDSIDSGSASPSSPVSESALCIPSSPKYDTLLIRDYTQSSSSL 1156  
chk5b  SVKEGTAETPSAKQDLEELVALTPPSPFRDSIDSGSASPSSPVSESALCIPSSPKYDTLLIRDYTQSSSSL 1188 
chk5f  SVKEGTAETPSAKQDLEELVALTPPSPFRDSIDSGSASPSSPVSESALCIPSSPKYDTLLIRDYTQSSSSL 1242 
chk5h                                                                          272  
       Homer Ligand        Homer Site 
 
 
Figure 2.2  The alignment of partial amino acid sequence for chicken mGluR5 splice 
variants.  The predicted amino acid sequence for the C-terminal portion for mGluR5 a, b, f, 
and h are shown.  The numbers at the right denote the position of the amino acid number.  The 
first 618 amino acids for mGluR5 a, b, and f have been omitted.  Asterisks denote differences 
between the sequences.  The gray boxes outline TMDs 2-7.  The Homer Ligand and Homer 
Site are underlined.   
 14
and Duvoisin 1998).  These domains have been well conserved across species.  Sequence 
analysis of chicken mGluR5 revealed that the amino acids in the intracellular loops 2 and 3 
that are critical for coupling to these G proteins were identical to those found in rat mGluR1 
and mGluR5 as well as human mGluR5 (Figure 2.3).  Although other intracellular domains 
probably contribute to the efficiency of G protein coupling, these results suggest that mGluR5 
can couple to both Gq and Gs. 
DISCUSSION 
Coupling to Different G Proteins 
 The conserved binding motifs within mGluR5 for the G proteins, Gq and Gs, suggest 
that either G protein can couple to mGluR5.  This finding is supported by evidence that 
activation of mGluR5 in cultured GABAergic amacrine cells can signal through either the 
PLC-dependent pathway, or via adenylate cyclase (see chapter 3; Unpublished results Sosa 
and Gleason).  In further support of this hypothesis, activation of rat mGluR5 expressed in 
LLC-PK1 kidney epithelial cells stimulates the production of both inositol phosphate and 
cAMP (Joly et al. 1995). 
A Novel Splice Variant 
Although it is clear that some mGluR5 splice variants are expressed in the chicken 
retina, it is not yet known whether mGluR5h is functionally expressed.  
Immunohistochemistry experiments using polyclonal antibodies raised against the final 21 
amino acids on the C-terminal tail of rat mGluR5 suggest that one or more mGluR5 subtypes 
(a, b, or f) are expressed by amacrine cells in the intact retina, while immunocytochemistry 
experiments with the same antibody along with Ca2+-imaging results indicate that mGluR5 is 
functionally expressed in cultured amacrine cells (Kreimborg et al. 2001; Sosa et al. 2002).   
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Rat mGluR1  RIARILAGSKKKICTRKPRFMSAWAQ....KTRNVPANFNEAK 
Rat mGluR5  RIARILAGSKKKICTKKPRFMSACAQ....KTRNVPANFNEAK 
Hum mGlur5  RIARILAGSKKKICTKKPRFMSACAQ....KTRNVPANFNEAK 
Chk mGluR5  RIARILAGSKKKICTKKPRFMSACAQ....KTRNVPANFNEAK 
 
      IL-2                                                      IL-3 
 
Figure 2.3  Chicken mGluR5 contains conserved sequences for coupling to G proteins 
Gq and Gs.  The amino acid sequences for chicken and human mGluR5 intracellular loops 2 
and 3 are aligned with rat mGluR1 and mGluR5.  The amino acids required for coupling to Gq 
are in shaded boxes, while those residues involved in Gs coupling are in open boxes.  
Residues required for coupling to either G protein are shown in bold.  The sequence and 
coupling data for rat mGluR1 and mGluR5 are adapted from Francesconi and Duvoisin 
(1998).       
 
However, because the truncated C-terminal tail of mGluR5h lacks the 21 residues recognized 
by the antibody, it remains unclear whether or not it is expressed.   
Homer proteins have been demonstrated to mediate post-translational control of 
functional expression of group I mGluRs.  Homer was initially identified as an immediate 
early gene that was up-regulated by LTP-inducing stimuli and whose gene product bound to 
the group I mGluRs (Brakeman et al. 1997; Kato et al. 1997).  Since then, three Homer gene 
families (Homer 1-3) were identified (Xiao et al. 1998).  Homer can influence the function of 
group I mGluRs by regulating surface expression (Roche et al. 1999; Ango et al. 2000), by 
co-localizing the receptors with components of downstream signaling pathways in post 
synaptic density signaling complexes (Tu et al. 1998; Tu et al. 1999; Kammermeier et al. 
2000), and by reducing the constitutive activity of these G protein coupled receptors (Ango et 
al. 2001).  The truncated receptor, mGluR5h, lacks the Homer ligand, a proline rich domain 
(PPXXF) that interacts with the coiled-coil region of Homer 1b and 1c (Tu et al. 1998), as 
well as the Homer site, where an EVH1-like domain of Homer 1a, 1b, and 1c can interact 
(Brakeman et al. 1997).  Thus, it is not known whether this truncated receptor will be targeted 
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to post-synaptic densities in the same manner as the mGluR5 splice variants with longer C-
terminal tails.   
Two shorter splice variants, mGluR5c and d, were previously identified from human.  
Human mGluR5c is the shortest variant with only 50 residues in its amino acid tail (US Patent 
5,521,297); however, little is known about the functionality of this particular mGluR5 splice 
variant.  Functional studies were performed with human mGluR5d, a splice variant with an in-
frame deletion of 299 amino acids and a C-terminal tail of only 86 amino acids.  This splice 
variant lacks only the Homer ligand while retaining the final 26 residues of the C-terminal 
domain containing the Homer site (Malherbe et al. 2002).  In-situ hybridization revealed 
expression of this splice variant in the brain, although at low levels.  When expressed in 
HEK293 cells, the functional properties of human mGluR5d were not significantly different 
from those of mGluR5a.  Therefore, it appears that the deleted 299 amino acids including the 
Homer ligand are not necessary for the functional expression of this truncated splice variant at 
the membrane.    
The mGluR1 splice variants may also provide some clues concerning the expression 
of mGluR5h.  The functional characteristics of the truncated mGluR1 splice variants, 
mGluR1b, mGluR1c, and mGluR1d, have been previously described.  Like the mGluR5 
splice variants, these shorter receptors differ from their full-length counterpart, mGluR1a, in 
the length of the intracellular C-terminal tail.  However, the functional characteristics of these 
receptors do appear to be affected by the shorter C-terminal domain.  When compared to the 
full-length mGluR1a, the short mGluR1 splice variants are less sensitive to agonists, 
demonstrate slower increases in intracellular Ca2+, and lack agonist-independent activity (Pin 
et al. 1992; Flor et al. 1996; Prezeau et al. 1996; Mary et al. 1998).  The shortest mGluR1 
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splice variant, mGluR1c, does functionally couple to G-proteins, as indicated by its agonist-
dependent ability to engender Ca2+ elevations.  Chicken mGluR5h, which has a C-terminal 
tail of 58 amino acids with a 7-residue insertion, is very similar to mGluR1c, which has a C-
terminal tail of 57 amino acids with a 10 amino acid insertion at the splice site.  Because the 
truncated variant, mGluR1c, was functionally expressed and transcripts were identified with 
in situ hybridization in the brain (Pin et al. 1992), it seems plausible that mGluR5h is 
functionally expressed in the retina.  
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INTRODUCTION 
Amacrine cells are a morphologically and functionally diverse group of interneurons 
that mediate signaling in the inner plexiform layer (IPL) of the vertebrate retina.  Although 
nearly thirty morphological classes of amacrine cells have been identified in the mammalian 
retina (MacNeil et al. 1998, 1999), it is not yet clear how each class contributes to signal 
processing in the IPL.  The GABAergic amacrine cells, the focus of this investigation, are one 
of the most common types of amacrine cells in the vertebrate retina.  GABAergic amacrine 
cells can receive excitatory synaptic input from glutamatergic bipolar cells and inhibitory 
synaptic input from other GABAergic amacrine cells.  These amacrine cells can make 
inhibitory synapses back onto bipolar cells, onto ganglion cells and onto other amacrine cells 
(Dowling and Boycott 1965; Dubin 1970; Hartveit 1999).  In the retina, synaptic input from 
bipolar cells depolarizes amacrine cells through the binding of glutamate to ionotropic 
glutamate receptors.  The expression of metabotropic glutamate receptors (mGluRs) on 
postsynaptic amacrine cell processes in the mammalian retina (Koulen et al. 1997; Cai and 
Pourcho 1999) expands the potential role of glutamate into a possible modulator of amacrine 
cell function.   
The mGluRs are an eight-member family of G protein-coupled receptors that are 
divided into three groups based on their sequence similarity and pharmacological properties 
(for review, see Conn and Pin 1997).  Activation of group I mGluRs (mGluRs 1 and 5) leads 
to elevations in cytosolic IP3 and Ca2+, and in some cells, to increases in cAMP (Aramori and 
Nakanishi 1992; Joly et al. 1995).  Groups II (mGluRs 2 and 3) and III (mGluRs 4, 6, 7, and 
8) are both negatively coupled to adenylate cyclase, such that receptor activation reduces 
production of cAMP.  
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Although it is well established that mGluR6 mediates synaptic transmission to ON 
bipolar cells, the role of other mGluRs in retinal function is poorly understood (Nakajima et 
al. 1993; Masu et al. 1995; Vardi et al. 1997, 1998).  In photoreceptors activation of mGluR8 
reduces the cytosolic Ca2+ concentration, but the underlying mechanism has not been resolved 
(Koulen et al. 1999).  In horizontal cells, activation of groups I and III mGluRs causes 
enhancement of voltage-gated Ca2+ currents (Linn and Gafka 1999), and activation of group 
III suppresses an inward rectifier current (Dixon and Copenhagen 1997).  In the inner retina, 
activation of group III mGluRs on bipolar cell terminals reduces neurotransmitter release 
(Awatramani and Slaughter 2001) but enhances neurotransmitter release from amacrine cells 
(Caramelo et al. 1999).  In ganglion cells, activation of group III mGluRs inhibits voltage-
gated Ca2+ currents (Shen and Slaughter 1998).  These studies indicate that mGluRs are 
present and functional in both the inner and outer retina.  Nonetheless, much remains to be 
learned about the intracellular targets of activated mGluRs and the impact of mGluR 
activation on signal processing in the retina. 
This study makes use of a culture system containing previously identified GABAergic 
amacrine cells (Gleason et al. 1993) and explores the role of a group I metabotropic glutamate 
receptor expressed by these cells.  Previous studies established that GABAergic amacrine 
cells express mGluR5 and that Ca2+ elevations can be engendered by activation of these 
receptors (Kreimborg et al. 2001).  Furthermore, the function of GABAA and GABAC 
receptors can be modulated by activation of PKA.  In the present report, the effects of 
mGluR5 activation are examined on the GABA-gated currents in individual amacrine cells 
and at their GABAergic synapses.   
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To begin to understand how activation of mGluR5 affects amacrine cell function, 
GABA-gated currents are recorded from individual amacrine cells using whole cell voltage-
clamp techniques.  Initially, the identity of the ionotropic GABA receptors expressed by these 
cells and the effects of mGluR5 activity on these receptors are examined.  A pharmacological 
approach is then used to uncover some aspects of the downstream signaling mechanisms 
involved.  Finally, to address whether modulation of GABAA receptors occurs at the synapse, 
we determine whether activation of mGluR5 alters the amplitude distribution of quantal 
events in amacrine cells.  Our findings indicate that activation of mGluR5 enhances 
GABAergic signaling between amacrine cells by modulating the function of postsynaptic 
GABAA receptors and that protein kinase C (PKC) is a key component of the signaling 
pathway.   
METHODS 
Cell Culture 
Chick retinal cultures were prepared as previously described (Gleason et al. 1992).  
Briefly, 8-day chick embryo retinas were dissociated in 0.1% trypsin and plated onto 35 mm 
plastic tissue culture dishes (Falcon, Oxnard, Ca) previously treated with 1 mg poly-L-
ornithine/ml (Sigma, St. Louis, MO).  Cells were plated at a density of 1.25 X 105 cells/35 
mm dish in Dulbecco’s Modified Eagle Medium (Sigma) supplemented with 5% fetal bovine 
serum (Hyclone, Logan, UT), 1000 U of penicillin/ml, 100 µg of streptomycin/ml, and 2 mM 
glutamine (Sigma).  Cultures were fed every 2-3 days with Neurobasal medium (Gibco Life 
Technologies, Rockville, MD) containing 0.5X B-27 supplement (Gibco), 1000 U of 
penicillin/ml, 100 µg of streptomycin/ml, and 2 mM glutamine (Sigma).  Cultures were 
incubated at 37ºC under a 5% CO2 atmosphere.   
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Electrophysiology 
Electrophysiology experiments were performed on isolated amacrine cells 6-10 days 
after plating.  Culture dishes were mounted on the stage of an Olympus IX70 inverted 
microscope equipped with Hoffman modulation contrast optics.  Whole cell voltage-clamp 
recordings were made using an Axopatch 1-D amplifier, Digidata 1200 data acquisition 
board, and Clampex 7.0 software (Axon Instruments, Union City, CA).  A reference Ag/AgCl 
pellet in 3M KCl was connected to the culture dish via an agar bridge containing 3M KCl.  
Patch electrodes were pulled from thick walled borosilicate glass (1.5 mm O.D., 0.86 mm 
I.D.; Sutter Instruments, Novato, CA) using a Flaming/Brown Puller (Sutter Instruments).  
Tip resistance values were 5-10 MΩ for ruptured-patch recordings and 3-5 MΩ for 
perforated-patch recordings as measured in the bath.  All recordings were made at room 
temperature (22-24ºC).   
To record whole cell GABA-gated currents, the ruptured-patch technique was used 
with the standard internal solution (see below).  Before recordings were made, RS values were 
monitored and allowed to stabilize.  Cells that exhibited unstable RS values during 
experiments were discarded from the data set.  The measured liquid junction potential for the 
standard recording solutions was 11 mV and this value was applied to the voltage values in I-
V plots.  For recording quantal events, the perforated-patch technique (Horn and Marty 1988) 
was used with Amphotericin B (Sigma) as the perforant.  The pipette solution was prepared 
fresh every 1-2 hours by making a 1:2 dilution of Amphotericin B (stock solution, 50 mg/ml 
DMSO) with Pluronic F-127 (stock solution, 25 mg/ml DMSO; Molecular Probes, Eugene, 
OR).  This mixture was sonicated for 30 seconds and then diluted in the perforated-patch 
internal solution to a final concentration of 200 µg/ml.   
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Solutions 
 Unless otherwise indicated, reagents were purchased from Sigma.  The standard 
extracellular solution contained (in mM) 116.7 NaCl, 5.3 KCl, 3.0 CaCl2, 0.41 MgCl2, 5.6 
glucose, 3.0 HEPES, and 20 TEA-Cl.  The pH was adjusted to 7.4 with NaOH.  For 
experiments recording quantal events, the external solution contained 300 nM Tetrodotoxin 
(TTX; Alomone Labs, Jerusalem, Israel) to block voltage-gated Na+ channels.  The standard 
internal solution for ruptured-patch recordings consisted of (in mM) 100 CsAc, 10 CsCl, 2 
MgCl2, 0.1 CaCl2, 1.1 EGTA, and 10 HEPES.  The pH was adjusted to 7.4 with CsOH.  The 
following ATP-regeneration reagents were added to the internal solution: 50 U/ml creatine 
phosphokinase, 3 mM adenosine 5’-triphosphate (ATP) dipotassium salt, 1 mM ATP-
disodium salt, 20 mM phosphocreatine (Calbiochem, La Jolla, CA), 2 mM guanosine 5’-
triphosphate (GTP) sodium salt.  ATP-dipotassium and ATP-disodium salts were prepared as 
1 M and 300 mM stocks respectively and stored at -20ºC.  The intracellular recording solution 
for perforated-patch recordings consisted of (in mM) 148.5 CsCl, 2 MgCl2, 0.1 CaCl2, 1.1 
EGTA, 10 HEPES.   
Stock solutions of (-)-7-octylindolactam V (Biomol Research Laboratories, Plymouth 
Meeting, PA), phorbol 12-myristate 13 acetate (PMA; Biomol), 1-oleoyl-2-acetyl-sn-glycerol 
(OAG; Biomol), and Gö6976 (Calbiochem) were prepared in DMSO and stored as single use 
aliquots at -20ºC up to 3 months.  When dissolved in external solution, the final DMSO 
concentrations did not exceed 0.1 %, and control experiments showed that DMSO at that 
concentration did not affect GABA-gated currents (Fig. 4).  GABA (Sigma) was routinely 
prepared as a 20 mM stock and stored at 4ºC.  50 mM (RS)-2-Chloro-5-
hydroxyphenylglycine (CHPG; Tocris Cookson, Ballwin, MO) stocks were prepared in 100 
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mM NaOH, and stored at -20ºC up to 1 week.  The final pH of external solutions containing 
CHPG was readjusted to 7.4 with HCl.  100 mM cis-4-aminocrotonic acid (CACA; Tocris) 
and 20 mM (1,2,5,6-tetrahydropyridine-4-yl) methylphosphinic acid (TPMPA; Tocris) stocks 
were prepared in water and stored at 4ºC.  Bicuculline methiodide, 1(S), 9(R) was dissolved 
directly in the external solution. 
During all experiments, cells were under continuous perfusion at a rate of 1-2 ml/min.  
Rapid solution changes were achieved using a tri-barrel square glass assembly (0.6 mm ID, 
0.1 mm wall; Warner Instruments, Hamden, CT) attached to a SF-77B Perfusion Fast Step 
(Warner Instruments) whose movement was controlled by the Clampex 7.0 software.  Each 
barrel of the assembly was supplied by a six to one manifold (Warner Instruments).  Manifold 
inlets were connected in various configurations to eight pressurized reservoirs.  Solution flow 
from the individual reservoirs was manually controlled using the ValveLink 8 system 
(Automate Scientific, Oakland CA).  GABA application was achieved in 10-20 ms through 
computer-controlled barrel movements.  GABA-gated currents were routinely elicited by 
switching to GABA-containing external for 500 ms at 30-second intervals.  All other solution 
changes were achieved in approximately 500 ms by opening and closing the valves upstream 
of a manifold feeding one common barrel.  Control experiments demonstrated that solution 
switching did not alter GABA-gated current amplitude (Fig. 3.4 A). 
Data Analysis 
Changes in current amplitudes (as plotted in Figures 2-7) were determined by 
calculating the difference between the peak GABA-gated current amplitude measured 
immediately before drug application and the peak current amplitude measured 30 seconds 
after the drug application.  Quantal events were analyzed using MiniAnalysis (Synaptosoft 
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Inc., Decatur, GA).  All events detected by the software were visually inspected to ensure 
correct peak and baseline selection.  Data are presented as the mean ± S.E.M.  Analyses of 
statistical significance was performed using either the unpaired (Figs. 3.2 and 3.3) or paired 
(Figs. 3.5-3.8) t-test. 
RESULTS 
Cultured Amacrine Cells Express GABAA Receptors 
 Amacrine cells were identified based on their morphology as previously described 
(Gleason et al. 1993).  Individual amacrine cells voltage-clamped at –70 mV produced an 
inward current in response to an external solution containing GABA.  To determine the dose-
response relationship, currents were measured in response to a range of GABA 
concentrations.  A sigmoid fit to the data resulted in a calculated EC50 of 50 ± 3 µM (Fig. 3.1 
A).  To prevent desensitization observed at high concentrations, experiments were performed 
with 20 µM GABA.  Voltage ramps delivered during GABA (20 µM) application produced 
currents that reversed at -58.2 ± 0.9 mV (n=5), near the predicted Cl- reversal potential for the 
standard internal and external solutions (Fig. 3.1 B).  GABA-gated current run-down was 
consistently observed during the recording period (routinely about 10 minutes, Fig. 3.1 C).  
Use of the perforated-patch technique did not prevent the current run-down suggesting that 
wash out of cytosolic components by the internal recording solution was not responsible for 
this run-down process. 
To determine the identity of the ionotropic GABA receptors, whole cell GABA-gated 
currents were recorded in the presence of a GABAA receptor antagonist, bicuculline, or a 












Figure 3.1  Amacrine cells express GABAA receptors.  A, A dose-response relation for 
peak current amplitudes elicited by 500 millisecond GABA applications of different 
concentrations gives a GABA EC50 of 59 µM.  The dose-response relationship and EC50 were 
calculated by Origin 6.0 (OriginLab Corp, Northampton, MA).  B, Leak-subtracted data from 
a representative amacrine cell whose membrane potential was ramped from –80 mV to -10 
mV in the presence of 20 µM GABA.  For this cell, the GABA-gated current reversed at –59 
mV, the predicted reversal potential for Cl-.  C, Peak Current amplitudes of inward currents 
elicited by 500 ms applications of 20 µM GABA every 30 seconds are normalized to the 
amplitude of the first response.  Average data are plotted from 11 cells.  D and E, Whole cell 
voltage-clamp recordings from individual amacrine cells.  D, GABA (20 µM) application 
produces an inward current that is blocked by bicuculline methiodide (50 µM).  E, TPMPA 
(20 µM), the GABAC specific antagonist, reduces GABA-gated currents.  F and G, whole 
cell recordings of CACA-elicited currents from the same amacrine cell.  F, CACA (100 µM) 
elicits a small current in amacrine cells, but TPMPA fails to block this current.  G, 






















































































completely blocked the GABA-gated currents suggesting that GABAA receptors are 
expressed (Fig. 3.1 D).  TPMPA (20 µM) reduced peak GABA responses by 10.5 ± 1.2% 
(Fig. 3.1 E, n=3), suggesting either that TPMPA interacted with GABAA receptors 
(Ragozzino et al. 1996) or that cultured amacrine cells expressed a small population of 
GABAC receptors.  To further investigate the possibility of GABAC receptor expression, the 
effects of CACA (100 µM), a GABAC receptor agonist, were examined.  CACA consistently 
evoked small inward currents (11.8 ± 1.5 pA; n=11).  Bicuculline blocked the CACA 
responses (n=5), but TPMPA was without effect (n=8; Fig. 3.1 F-G).  Thus, the small effects 
of CACA were most likely due to interactions with a population of α6-containing GABAA 
receptors (Wall 2001, see discussion).  These results suggest that GABAA receptors are the 
only ionotropic GABA receptors expressed by cultured amacrine cells. 
 Amacrine cells can express metabotropic GABAB receptors (Tian and Slaughter 1994; 
Catsicas and Mobbs 2001), and it is possible that the steady change in GABA-gated current 
amplitudes (run-down) is due to slow modulation of the GABAA receptors by GABAB 
receptors.  To address whether run-down was due to activation of GABAB receptors, we 
applied the GABAA receptor-specific agonist, isoguvacine (100 µM), in place of GABA.  As 
for currents elicited with GABA, isoguvacine-dependent current amplitudes decreased over 
time (data not shown, n=4).  These results indicated that activated GABAB receptors were not 
responsible for the GABAA receptor current run down observed in cultured amacrine cells. 
Activation of mGluR5 Enhances GABA-Gated Currents 
To determine if activation of mGluR5 modulates GABAA receptor function, GABA-
gated currents were recorded in the presence of CHPG, an mGluR5-specific agonist (Doherty 
et al. 1997).  In 9 of 14 cells initially examined, application of CHPG (300 µM) enhanced 
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GABA-gated currents by 10.0 ± 1.5% (Fig. 3.2).  Throughout these experiments, CHPG 
modulated GABA-gated currents in about 66% of the cells.  For subsequent experiments, the 
data are reported only for responding cells.  Enhancement typically occurred within 30 
seconds and persisted for the duration of CHPG exposure.  We consistently observed that 
CHPG-enhanced GABA-gated currents had faster decay kinetics than control (Fig. 3.2 B).  
Dose-response experiments showed that, in general, larger amplitude currents had faster 
decay rates, suggesting this effect was not necessarily a direct result of CHPG application.  
The rate of GABA-gated current run down persisted in CHPG-treated cells.  Voltage ramps 
delivered during GABA applications revealed no significant differences in the chloride 
reversal potential before (58.2 ± 0.8 mV) and during (57.2 ± 2.8 mV) CHPG application (data 
not shown; p=0.655, n=5).  This result indicates that the effect of mGluR5 activation on the 
GABA-gated current amplitude is not due to a shift in the chloride reversal potential. 
A previous study demonstrated that activating mGluR5 leads to increases in 
intracellular calcium in cultured amacrine cells (Kreimborg et al. 2001).  To determine 
whether these rises in cytosolic calcium are required for the modulation of GABA-gated 
currents, BAPTA, a fast Ca2+ chelator, was added to the standard internal solution to buffer 
the increases in intracellular calcium.  For all cells examined, including BAPTA (10 mM) in 
the recording pipette blocked the current enhancement produced by CHPG (Fig. 3.3 A-B,E; 
n=5).  Changes in normalized current amplitudes for BAPTA-treated cells following CHPG 
application averaged -2.0 ± 1.3% and were not significantly different (p=0.916) from those 
observed in control cells (-1.6 ± 1.5%).  Recordings made on the same day with the standard 



















































Figure 3.2  (RS)-2-chloro-5-hydroxyphenylglycine (CHPG) enhances GABA-gated 
currents in amacrine cells.  A, peak GABA-gated current amplitudes are normalized to the 
current amplitude recorded just prior to CHPG application.  The horizontal bar indicates the 
timing of CHPG (300 µM) application.  B, whole cell voltage-clamp recordings of GABA-gated 
currents denoted in part A, before (a) and during (b) CHPG application.  C, On average, CHPG 



















































































Figure 3.3  Buffering internal Ca2+ levels inhibits the CHPG-dependent enhancement.  A, 
GABA-gated current amplitudes recorded when BAPTA was included in the internal solution. 
B, Whole cell voltage-clamp recordings (denoted in A) before (a) and during (b) CHPG 
exposure. C, Control experiments performed on the same day with normal internal solution (no 
BAPTA) confirmed that cells were responsive to CHPG. D, Whole cell voltage-clamp 
recordings (denoted in C) before (a) and during (b) CHPG application. E, Comparison of 
CHPG responses in BAPTA treated cells to CHPG responses in cells recorded with normal 
internal solution (1.1 mM EGTA) shows that BAPTA inhibits the CHPG response (*P < 
0.0001). The average change in current observed during control experiments for the same time 
frame (Fig 1C) is also plotted for reference.
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internal calcium buffering was reduced (Fig. 3.3 C-D; n=2).  These results are consistent with 
the modulation of GABAA receptor currents through a calcium-dependent pathway. 
Activation of PKC Enhances GABA-Gated Currents 
Although an increase in intracellular calcium by activated mGluR5 has the potential to 
stimulate multiple effectors, the conventional downstream signaling pathway associated with 
mGluR5 involves the lipid- and calcium-dependent PKC isotypes.  To determine if PKC 
activity enhanced GABA-gated currents in amacrine cells, GABA-gated currents were 
recorded in the presence of cell-permeable PKC activators.  Within 30 seconds of application, 
(-)-7-octylindolactam V (250 nM) increased the mean current amplitude by 15.1 ± 1.8%, and 
current amplitudes increased up to 27.6 ± 2.5% during the two-minute application window 
(Fig. 3.4 A-B; n=6).  I-V plots showed that like CHPG, octylindolactam did not alter the 
reversal potential of GABA-gated currents (n=4, data not shown).  A diacylglycerol analogue, 
1-oleoyl-2-acetyl-sn-glycerol (OAG), and a phorbol ester, phorbol 12-myristate 13 acetate 
(PMA), also reversibly enhanced GABA-gated currents in a dose-dependent manner (Fig. 3.4 
C).  In most cases, the GABA-gated current enhancement achieved with activation of PKC 
was considerably larger than that observed with activation of mGluR5.  One possible 
explanation for this discrepancy is that only Ca2+-dependent PKC isotypes are activated by the 
mGluR5 signaling pathway whereas the PKC activators stimulate all subtypes of PKC. 
Alternatively, this discrepancy might indicate that the PKC activators stimulate a larger 
fraction of available PKC molecules.   
Although 500 nM octylindolactam produced larger increases in GABA-gated current 
amplitudes, 250 nM octylindolactam was less toxic to the cells and allowed for experiments 

























































Figure 3.4  PKC activation enhances currents through GABAA receptors.  A, Application 
of 250 nM octylindolactam enhances GABA-gated currents. DMSO, the solvent for the PKC 
activators (0.1%), did not affect GABA-gated currents.  B, Voltage-clamp recordings 
(denoted in A) before (a) and during (b) octylindolactam application.  C, Octylindolactam, 
OAG, and PMA each enhance GABA-gated currents. Plotted are mean changes in peak 
current amplitude after 30 s of drug application.     
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applications, even at the lowest concentrations used.  Therefore, in most subsequent 
experiments, octylindolactam (at 250 nM) was used to activate PKC.  Together, the results 
from the three PKC activators suggest that activation of PKC also leads to enhancement of 
currents through GABAA receptors in amacrine cells.    
PKC Activity is Required for mGluR5-Dependent Modulation of GABAA Receptors  
To test whether mGluR5-dependent modulation of GABA-gated currents occurs via 
PKC activation and if so whether the mGluR5-dependent enhancement could be occluded, 
PKC was stimulated before activation of mGluR5.  To accomplish this, octylindolactam was 
applied until a plateau in the PKC-dependent enhancement of GABA-gated current was 
achieved.  CHPG was then applied in the continued presence of octylindolactam.  When 
CHPG was applied to a cell that had been pre-stimulated with octylindolactam, no additional 
enhancement was observed (Fig. 3.5; n=7).  Both CHPG (300 µM) and octylindolactam (250 
nM) independently enhanced GABA-gated currents by 8.4 ± 1.4% and 20.7 ± 3.2% 
respectively. 
If PKC activity is critical for the mGluR5-dependent enhancement of GABA-gated 
currents, then inhibiting PKC activity should block this effect.  Exposure of the general PKC 
inhibitors such as staurosporine (150 nM), sphingosine (3um), and calphostin C (2.5 and 0.5 
µM), caused the recordings to become unstable.  Interestingly, Ca2+ imaging experiments 
performed with the Ca2+ indicator fluo-3, revealed large and usually irreversible increases in 
cytosolic calcium during exposure to sphingosine consistent with cell damage (Gleason 
unpublished observations).  Gö6976, a selective inhibitor of Ca-dependent isotypes of PKC, 
was less toxic than other PKC inhibitors when used at 25-35 nM, a concentration slightly 
above its reported EC50 value of 7.9 nM (Martiny-Baron et al. 1993).  Application of Gö6976  
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Figure 3.5  mGluR5-dependent enhancement of GABAA receptor currents is occluded 
by pre-activation of PKC.  A, Peak current amplitudes of GABA-gated currents are plotted 
over time for a representative amacrine cell.  CHPG (300 µM) enhances GABA-gated 
currents unless PKC has been pre-activated by octylindolactam (250 nM).  B, Voltage-clamp 
recordings (denoted in A) before (a) and during (b) CHPG application, before (c) and during 
(d) octylindolactam application, and during co-application of CHPG and octylindolactam (e). 
C, Applying CHPG in the presence of octylindolactam produces no significant change in the 
GABA-gated peak current amplitudes (n=7; *P = 0.001).
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by itself enhanced GABA-gated currents by 3.3 ± 1.4% (n=20).  This finding was unexpected, 
given the enhancement observed with the PKC activators.  Application of other general PKC 
inhibitors also enhanced GABA-gated currents before their toxic effects were observed.  The 
exact source of this effect is unknown but may be attributable to the inhibition of basal PKC 
activity. 
To establish that Gö6976 inhibited PKC-dependent GABA-gated current 
enhancement, currents were recorded while octylindolactam was applied alone and in the 
presence of Gö6976.  Octylindolactam (100 nM) alone enhanced GABA-gated currents by 
13.25 ± 2.49%, (n=8), and Gö6976 alone significantly enhanced GABA-gated currents by 
1.55 ± 1.18%.  Pre-application of Gö6976 significantly suppressed the effects of 
octylindolactam (p=0.016), reducing the current enhancement to only 5.08 ± 0.94% (Fig. 3.6 
A-C). 
To determine whether inhibition of PKC also inhibits the mGluR5-dependent 
enhancement of GABA-gated current, the effects of Gö6976 on CHPG responses were 
examined.  In co-application experiments similar to those described previously, activation of 
mGluR5 with CHPG (300 µM) alone enhanced the GABA-gated currents by 13.3 ± 3.3% 
(n=5).  After washing out the CHPG, applying Gö6976 (35 nM) alone also enhanced the 
currents, in this subset of cells, by 8.2 ± 3.3% (n=5).  However, no CHPG-dependent 
enhancement was observed in the presence of the inhibitor.  Importantly, CHPG-dependent 
enhancement was restored after washing out the Gö6976 (Fig. 3.7 A-C).  Together, these 
results suggest that activated mGluR5 enhances whole cell GABA-gated currents via 






























































Figure 3.6  PKC-dependent enhancement is inhibited by Gö6976. A, Peak current 
amplitudes of GABA-gated currents are plotted for a representative amacrine cell. 
Octylindolactam (100 nM) and Gö6976 (35 nM), an inhibitor of Ca2+-dependent PKC 
isotypes, both enhance GABA-gated currents when applied alone. In the presence of 
Gö6976, current enhancement by octylindolactam is inhibited. B, Voltage-clamp recordings 
(denoted in A) before (a) and during (b) octylindolactam application, before (c) and during 
(d) Gö6976 application, and during co-application of octylindolactam and Gö6976 (e). C, On 
average, Gö6976 inhibits the PKC-dependent enhancement of GABA-gated currents 
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Figure 3.7  CHPG-dependent enhancement is inhibited by Gö6976.  A, Peak current 
amplitudes of GABA-gated currents are plotted over time for a representative amacrine cell. 
CHPG (300 µM) and Gö6976 (35 nM) both enhance GABA-gated currents. In the presence of 
Gö6976, CHPG does not enhance GABA-gated currents. Washing out the Gö6976 restores the 
CHPG-dependent enhancement. Applying Gö6976 during CHPG application reduces the 
mGluR5-dependent enhancement of GABA-gated currents.  B, Voltage-clamp recordings 
(denoted in A) before (a and f) and during (b and g) CHPG application, before (c) and during 
(d) Gö6976 application, and during co-application of CHPG and Gö6976 (e and h).  C, CHPG-
dependent enhancement of GABA-gated currents is suppressed when PKC is inhibited by 
Gö6976 (n=6; *P = 0.02).
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CHPG Increases Mean Amplitude of Quantal Events 
Isolated amacrine cells form GABAergic synapses onto themselves, or autapses, after 
9-10 days in culture as previously described (Gleason et al. 1994; Frerking et al. 1995).  Thus, 
it was possible to ask whether activation of mGluR5 modulated postsynaptic GABAA 
receptors specifically.  Using perforated-patch voltage-clamp recordings to minimize washout 
of synaptic activity, quantal release was promoted at autapses by holding the cell’s membrane 
potential between –40 and –50 mV, near the foot of the activation curve for voltage-gated 
calcium currents (Gleason et al. 1994).  To provide better resolution of the quantal events, a 
high Cl- internal solution was used that gave a predicted ECl of 0 mV.   
In agreement with previous recordings of synapses between pairs of amacrine cells 
(Gleason et al. 1993), the amplitude distribution of quantal events recorded was positively 
skewed and exhibited some very large and rare events (Fig. 3.8 B).  Application of CHPG 
reversibly enhanced the mean peak amplitude of quantal events in 5 of 6 cells examined.  For 
the remaining cell, the mean peak amplitude was slightly, but non-significantly, increased 
(p=0.610) in the presence of CHPG.  On average, CHPG significantly increased the mean 
quantal current amplitude by 18% (p=0.014, n=6; control=9.0 ± 0.8 pA, CHPG = 11.6 ± 0.8 
pA; Fig. 3.8 C).  In 3 of the 5 responding cells, cumulative frequency curves from data 
collected in CHPG were shifted to the right over the full range of amplitudes (Fig 3.8 Da, b).  
In the other 2 cells, the shift was biased towards larger events (Fig. 3.8 Dc).      
DISCUSSION 
Our results indicate that cultured retinal amacrine cells express GABAA, but not 
GABAC, ionotropic GABA receptors.  Furthermore, the activity of these GABAA receptors is 
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Figure 3.8  CHPG increases the mean peak amplitude of GABAergic quantal events in 
isolated amacrine cells.  A, Representative recording of autaptic currents in an isolated 
amacrine cell in culture.  B, Amplitude distributions show that CHPG application reversibly 
increases the mean peak amplitude of the GABAergic quantal events in an amacrine cell. Data 
were collected for 90 seconds before, during, and after CHPG (300 µM) application.  C, 
Averages of the mean quantal amplitude data from 6 cells are plotted. CHPG significantly 
increased the mean peak amplitude by 18%. (*P = 0.01).  D, Cumulative frequency plots of 
quantal events recorded from individual amacrine cells before (dark trace) and during (light 
trace) CHPG application.  The curves shown in a and b are positively shifted over the full range 
of amplitudes in the presence of CHPG.  The data shown in A and B are from the same cell as 
the data shown in a.  In the third cell shown (c), the shift occurred primarily at larger 
amplitudes.  
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indicate that this effect is Ca2+-dependent.  Pharmacological experiments suggest that the 
mGluR5-dependent enhancement is mediated by PKC, and recordings of quantal events 
indicate that mGluR5 activation specifically enhances currents through postsynaptically 
localized GABAA receptors.  Together, these observations are consistent with glutamate 
release from bipolar cells acting as a modulator of amacrine cell function. 
Modulation of GABA-Gated Currents by PKC  
Activation of PKC was shown to modulate GABAA receptors in other systems, but the 
outcomes of the modulation have been variable (for review see Moss and Smart 1996; Swope 
et al. 1999).  Previous studies on both native and heterologously expressed receptors 
demonstrated that pharmacological activation of PKC produces inhibition of GABAA 
receptor-mediated currents (Sigel et al. 1991; Kellenberger et al. 1992; Leidenheimer et al. 
1992; Krishek et al. 1994; Gillette and Dacheux 1996; Tapia et al. 1997; Connolly et al. 1999; 
Brandon et al. 2000; Filippova et al. 2000).  This inhibition was attributed to either direct 
phosphorylation of receptor subunits (Brandon et al. 2000) or to alterations in the levels of 
GABAA receptor surface expression (Connolly et al. 1999; Filippova et al. 2000). 
In contrast to these reports of PKC-dependent inhibition of GABA-gated currents, 
intracellular delivery of constitutively active PKC subunits enhanced GABAA receptor-
mediated currents through recombinant receptors expressed in mouse L929 cells (Lin et al. 
1994, 1996).  Similarly, addition of constitutively active PKC subunits into rat dentate gyrus 
cells also increased the conductance of GABAA receptor-mediated synaptic currents 
(Poisbeau et al. 1999).  Although these results implied that the method of PKC activation 
(pharmacologically versus introduction of active subunits) correlated with the outcome of 
GABAA receptor modulation, our results showing enhancement of GABA-gated currents after 
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pharmacological activation of PKC argue against this scenario.  Instead, the different 
modulatory effects of PKC on GABA-gated currents are likely to be due to factors intrinsic to 
different neuronal cell types.  In support of this, Poisbeau et al. (1999) demonstrated that 
introducing constitutively active PKC subunits into dentate gyrus granule cells enhanced 
GABAA receptor function, but had no effect in CA1 pyramidal cells. 
The different modulatory effects of PKC may be due to the heterogeneity of GABAA 
subunit expression in different neuronal populations.  The binding patterns of subunit-specific 
antibodies in the IPL of the mammalian retina indicate that GABAA receptors can be 
assembled in a variety of subunit combinations (Greferath et al. 1995; Wässle et al. 1998).  
Although the full complement of GABAA subunits expressed by these GABAergic amacrine 
cells is currently unknown, two pieces of evidence suggest that cultured amacrine cells 
express α6 subunits.  Wall (2001) demonstrated that GABAA receptors containing α6 
subunits produced CACA-dependent currents that were insensitive to TPMPA.  Thus, our 
finding that bicuculline-sensitive and TPMPA-insensitive currents were elicited by CACA in 
these cells is consistent with the expression of the α6 subunit.  GABA-gated currents in 
cultured chick amacrine cells were found to be sensitive to furosemide (Borges and Wilson, 
pers. comm), an agent known to selectively inhibit GABA-gated currents in α6-expressing 
cells (Korpi et al. 1995; Wafford et al. 1996; Thompson et al. 1999).   
Additionally, two novel GABAA subunits, β4 and γ4, were identified and sequenced 
from chick whole brain cDNA libraries (Bateson et al. 1991; Harvey et al. 1993).  These 
subunits are capable of forming functional channels (Liu et al. 1998; Forster et al. 2001), but 
little is known concerning their modulation by PKC.  Although functional expression of the 
β4 and γ4 subunits in the retina has not yet been demonstrated, in-situ hybridization revealed 
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that mRNA for the γ4-subunit is present in the inner nuclear layer of the retina, suggesting 
that a population of amacrine cells express this novel GABAA subunit (Harvey et al. 1994).  
Further elucidation of the subunit expression pattern in amacrine cells may shed light on the 
mechanisms underlying the effects of PKC on GABAA receptors.  
The Role of mGluR5 at Amacrine Cell Synapses 
The finding that activated mGluR5 enhances GABA-gated postsynaptic currents in 
cultured GABAergic amacrine cells indicates that in the retina glutamate might modulate 
synaptic interactions between amacrine cells.  Activation of mGluRs was previously shown to 
affect GABAergic signaling at central synapses, but in each case the modulation targeted 
presynaptic mechanisms (Stefani et al. 1994; Gereau and Conn 1995; Poncer et al. 1995, 
2000; Schrader and Tasker 1997; Semyanov and Kullmann 2000).  The mGluR5-dependent 
enhancement of mean quantal event amplitudes suggests that a postsynaptic mechanism is 
targeted in amacrine cells.  This interpretation is supported by our observation that whole cell 
GABA-gated currents are also enhanced.  Interestingly, the percent of current enhancement of 
the quantal events is almost twice that observed for whole cell currents.  There are two 
possible interpretations of this observation.  It may be that the components of the signaling 
apparatus that sub-serve the effects of mGluR5 activation are postsynaptically (with respect to 
incoming GABAergic synapses) localized in order to preferentially target synaptic GABAA 
receptors for modulation.  There is precedence for such an arrangement where β2 adrenergic 
receptors, components of their signaling pathway, and their targets (L-type Ca2+ channels) are 
co-localized by virtue of interactions with cytoskeletal elements (Davare et al. 2001).  It has 
also been demonstrated that GABAA β subunits can be physiologically associated with PKC 
(Brandon et al. 1999).   
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The second scenario is that activation of mGluR5 also has an effect on presynaptic 
function.  Multiple potential targets can be envisioned.  One possibility is that at the synapse, 
activation of mGluR5 also augments filling of vesicles such that an enhancement in current 
amplitude is due to both changes in receptor behavior and the presence of a higher 
concentration of GABA.  Another possibility is that mGluR5-dependent Ca2+ elevations 
increase the frequency of exocytosis and may generate simultaneous vesicle fusions that 
would be detected postsynaptically as a single, large quantal event (Llano et al. 2000).  At 
present, we think this is unlikely because activation of mGluR5 in the absence of voltage-
gated Ca2+ channel activation has not been observed to stimulate exocytosis in this 
preparation.  It remains possible, however, that mGluR5-dependent release of Ca2+ from 
internal stores, together with voltage-gated Ca2+ channel activation would be sufficient to 
trigger simultaneous fusion events. Simultaneous events such as these might explain the 
increase in large amplitude quantal events that we observed in 2 of the 6 cells examined (see 
Fig. 3.8 Dc). 
How might the enhancement of GABAergic synaptic transmission affect signaling in 
the inner retina?  One simple scenario would involve an amacrine cell process that is 
postsynaptic to a bipolar cell and also postsynaptic to a GABAergic amacrine cell.  In this 
configuration, glutamate would enhance the efficacy of the synapse from the GABAergic 
amacrine cell and suppress the depolarization mediated by ionotropic glutamate receptors.  
This sort of anatomical arrangement has been described for the wide-field A22 amacrine cell 
of the cat retina (Kolb 1997).  This cell is itself GABAergic and a single process can be 
postsynaptic to both bipolar cell and amacrine cell processes.  Given the recent estimate that 
92% of non-ribbon synapses in the IPL are GABAergic (Marc and Liu 2000), it seems likely 
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that contacts of this type frequently occur.  These interactions would have the potential to be 
highly localized because of the nature (both serial and reciprocal) of amacrine cell synapses in 
the IPL.  
It has been reported that bipolar cells can make ribbon synapses directly onto amacrine 
cell bodies (Dowling and Boycott 1965).  Immunocytochemical evidence indicates that 
mGluR5 can also be expressed at cell bodies of amacrine cells in the intact retina (Kreimborg 
et al. 2001).  Thus, the Ca2+ signaling engendered by activation of these receptors might alter 
amacrine cell function on a more global and long-term basis by activating Ca2+-dependent 
transcriptional regulation pathways.  This type of transcriptional regulation was previously 
observed in rat striatal neurons, where activation of Group I mGluRs led to phosphorylation 
of the MAP-K signaling components, ERK and Elk-1, as well as the transcriptional activator, 
cAMP response element-binding (CREB) protein (Choe and Wang 2001; Mao and Wang 
2002).  Understanding the degree to which activation of mGluR5 generates local signaling 
events in amacrine cells will be important in elucidating the full effect of glutamate on 
amacrine cell function and signaling in the IPL.  
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The production of nitric oxide (NO) by the inducible (Ca2+-sensitive) form of the 
synthetic enzyme, neuronal nitric oxide synthase (nNOS), can potentially be activated by any 
stimulus capable of increasing the intracellular concentration of Ca2+.  Traditionally, NO 
signals through its interaction with the heme-moiety of soluble guanylate cyclase (sGC), 
which leads to the production of cGMP.  Kinetic analysis of the NO/sGC signaling pathway 
has shown that cGMP levels increase within 40 ms after NO production (Bellamy and 
Garthwaite 2001), indicating that NO-dependent signaling can occur quickly in response to 
NO-generating stimuli.  Signaling through cGMP can occur through three different 
mechanisms, activation of cGMP-dependent protein kinase (PKG), activation of cyclic-
nucleotide gated channels, or activation of cGMP-sensitive phosphodiesterase.  In addition to 
the traditional NO/cGMP signaling pathways, NO can also affect target proteins through S-
nitrosylation (Davis et al. 2001).  This covalent modification of thiol groups on cysteine 
residues requires higher concentrations of NO and proceeds with slower kinetics than the 
NO/cGMP signaling pathways.     
Nitric oxide has been detected in each class of cell in the vertebrate retina (Neal et al. 
1998; Fischer and Stell 1999; Blute et al. 2000; Ríos et al. 2000; Eldred 2001; Blute et al. 
2003).  In the inner retina of the chicken, a subset of amacrine cells expresses high levels of 
nNOS, and distinct layers of nNOS labeling occur throughout the inner plexiform layer (IPL) 
of the retina (Fischer and Stell 1999; Crousillac et al. 2003).  The possibility that NO might 
function as a modulator in the inner retina was revealed when it was demonstrated that NO 
reduced gap-junction coupling between AII amacrine cells and cone bipolar cells in the retina 
(Mills and Massey 1995).  A similar effect on gap junction coupling was also demonstrated 
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for horizontal cells in the outer retina (Miyachi et al. 1990; Xin and Bloomfield 2000).  For 
the most part, however, the role of NO in the inner retina remains unknown.   
In order to begin to understand how NO signaling affects the function of GABAergic 
amacrine cells, whole cell recordings were made from chicken amacrine cells in culture.  By 
exposing the cells to NO-donors and NO-bubbled solutions, it was revealed that NO can 
modulate the function of GABAergic amacrine cells by affecting both the functional 
properties of GABAA receptors, and by altering the apparent chloride reversal potential (ECl-).  
Together, these results suggest that NO production in the inner retina can modulate the 
function of GABAergic amacrine cells and affect retinal processing within the IPL.       
METHODS 
Cell Culture 
Unless otherwise indicated, all reagents were purchased from Sigma, St. Louis, MO.  
Age of cultures is indicated by embryonic equivalent (EE 1 – EE 21) or post-hatch equivalent 
(PE 1) days.  Chick retinal cultures were prepared as previously described (Gleason et al. 
1992).  Briefly, 8-day chick embryo retinae (EE 8) were dissociated in 0.1% trypsin and 
plated onto 35 mm plastic tissue culture dishes (Falcon, Oxnard, Ca) previously treated with 1 
mg poly-L-ornithine/ml.  Cells were plated at a density of 1.25 X 105 cells/35 mm dish in 
Dulbecco’s Modified Eagle Medium supplemented with 5% fetal bovine serum (Hyclone, 
Logan, UT), 1000 U of penicillin/ml, 100 µg of streptomycin/ml, and 2 mM glutamine.  
Cultures were fed every 2-3 days with Neurobasal medium (Gibco Life Technologies, 
Rockville, MD) containing 0.5X B-27 supplement (Gibco), 1000 U of penicillin/ml, 100 µg 
of streptomycin/ml, and 2 mM glutamine.  Cultures were incubated at 37ºC under a 5% CO2 
atmosphere.   
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Immunocytochemistry 
All methods employing live animals were approved by the Louisiana Sate University 
Institutional Animal Care and Use Committee in accordance with National Institutes of 
Health guidelines.  Retinal tissue was obtained from White Leghorn chickens (Gallus gallus 
domesticus) from the Poultry Sciences Department, Louisiana State University.  The chickens 
were sacrificed by cervical dislocation and decapitation.  The eyes were enucleated and the 
anterior 1/3 of the eye was cut away to expose the eyecup.  The vitreous was removed and the 
retinae were fixed by adding 4% paraformaldehyde to the eyecup for 10 minutes.  The retinae 
were then excised from the eyecup and placed in fresh fixative.  The retinal tissue was kept in 
fixative for 2 hours at 4°C.  The peripheral 20% of the retinae was discarded and the 
remaining retinae were embedded in O.C.T. compound (Sakura Finetek, Torrence CA) by 
freezing on a slurry of dry ice and isopentane.  Embedded tissues were stored at –80°C.  
Sections (14-17 µm) were cut from the embedded tissue on an American Optical Cryostat.  
For the experiments done in culture, cells were plated on 22 mM square glass coverslips 
(Assistant, Germany) coated with 1 mg/ml poly-L-ornithine.  The cells were fixed in 1% 
paraformaldehyde for 30 minutes at 4°C then rinsed in phosphate buffered saline (PBS). 
For sections and cultured cells, a blocking step was performed prior to antibody 
application, by incubating retinal sections or cultured cells in PBS containing 5% normal goat 
serum, 1% BSA, and 0.5% saponin for 1 hour. 
For double labeling experiments, the primary and secondary antibodies for NKCC and 
then KCC2 were sequentially applied.  The primary antibody raised against NKCC was a 
monoclonal antibody (T4 antibody, University of Iowa Developmental Studies Hybridoma 
Bank) and was used at a dilution of 1:100.  Controls for this antibody were performed by first 
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incubating samples in NS1 (the supernatant from the fusion cell line) at a concentration of 
1:10, followed by incubation in the appropriate secondary.  The primary antibody against 
KCC2 (polyclonal, Upstate Biotechnology, Lake Placid, NY) was used at a dilution of 1:400.  
Secondary only controls were performed for KCC2.  The secondary antibodies used with the 
anti-NKCC were goat anti-mouse conjugated to either the Cy3 or Alexa-488 fluorochromes 
(Molecular Probes, Eugene, OR).  The secondary for the anti-KCC2 was a cy3-conjugated 
goat anti-rabbit.  All secondary antibody concentrations were at 1:500. 
For all experiments, samples were coverslipped  in mounting medium (70% glycerol, 
28% PBS, 2% n-propyl gallate, w/v).  Cells and sections were visualized on a Nikon 
microphot-FXA upright microscope with epifluorescence optics.  For visualization of the 
double-labeled material, a 515-545 band pass emission filter was used to eliminate the bleed-
though from the Cy3 signal into the other channel.  Images of double-labeled cultured cells 
were visualized using a DAPI/FITC/Cy3 filter set (Chroma Technology Corp, Rockingham, 
VT).  Digital images were captured with an Insight RT Slider camera and Spot Advanced 
software (Diagnostic Instruments, Sterling Heights, MI).  Images were assembled in Adobe 
Photoshop 7.0 (San Jose, CA).  All adjustments to the appearance of the images were the 
same for control and experimental images. 
Electrophysiology 
Electrophysiological experiments were performed on isolated amacrine cells 6-14 days 
(EE 14 – PE 1) after plating.  Culture dishes were mounted on the stage of an Olympus IX70 
inverted microscope equipped with Hoffman Modulation Contrast optics.  Whole cell 
recordings were made using an Axopatch 1-D amplifier, Digidata 1200 data acquisition 
board, and Clampex 8.0 software (Axon Instruments, Union City, CA).  A reference Ag/AgCl 
 59
pellet in 3M KCl was connected to the culture dish via an agar bridge containing 3M KCl.  
Patch electrodes were pulled from thick walled borosilicate glass (1.5 mm O.D., 0.86 mm 
I.D.; Sutter Instruments, Novato, CA) using a Flaming/Brown Puller (Sutter Instruments).  
Tip resistance values were 5-10 MΩ for ruptured-patch recordings and 3-5 MΩ for 
perforated-patch recordings as measured in the bath.  All recordings were made at room 
temperature (22-24ºC).   
Perforated-patch recordings were made by including gramicidin D (10 µg/ml) in the 
internal solution.  Gramicidin stocks were prepared daily in ethanol at 10 mg/ml.  For 
perforated-patch recordings, stable RS values were obtained within 20-40 minutes after 
obtaining a GΩ seal.  RS values were monitored during all experiments (ruptured- and 
perforated-patch).  Cells exhibiting unstable RS values were discarded from the data set.  For 
voltage ramp experiments, leak currents were first recorded by delivering voltage ramps in the 
absence of GABA.  The leak current was then subtracted from GABA-gated currents recorded 
during voltage ramp delivery.  The leak-subtracted data was then corrected for junction 
potential errors.  Junction potentials were measured and/or calculated (using the junction 
potential calculator, Clampex 8.0) for each internal and external combination.   
Solutions 
During all electrophysiological experiments, cells were under continuous perfusion at 
a rate of 1-2 ml/min.  Rapid solution changes were achieved using a tri-barrel square glass 
assembly (0.6 mm ID, 0.1 mm wall; Warner Instruments, Hamden, CT) attached to a SF-77B 
Perfusion Fast Step (Warner Instruments) whose movement was controlled by the Clampex 
8.0 software.  Each barrel of the assembly was supplied by a six to one manifold (Warner 
Instruments).  Manifold inlets were connected in various configurations to eight pressurized 
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reservoirs.  Solution flow from the individual reservoirs was computer controlled by Clampex 
8.0 through the ValveLink 8 system (Automate Scientific, Oakland CA).  GABA application 
was achieved in 10-20 ms through computer-controlled barrel movements.  All other solution 
changes were achieved in approximately 500 ms by opening and closing the valves upstream 
of a manifold feeding one common barrel. 
The compositions of external and internal solutions are shown in Tables 4.1 and 4.2 
respectively.  With the exception of the zero Cl- external, TTX (330 nM) and LaCl3 (25 µM) 
were added to external solutions prevent activation of voltage-gated Na+ and Ca2+ channels.  
For ruptured-patch recordings, the following ATP-regeneration reagents were added to 
internal solutions: 50 U/ml creatine phosphokinase, 3 mM adenosine 5’-triphosphate (ATP) 
dipotassium salt, 1 mM ATP-disodium salt, 20 mM phosphocreatine (Calbiochem, La Jolla, 
CA), 2 mM guanosine 5’-triphosphate (GTP) sodium salt.  ATP-dipotassium and ATP- 
disodium salts were prepared as 1 M and 300 mM stocks respectively and stored at -20ºC.   
Normal TEA Zero K+ Zero Na+ Zero Na+/K+ Equal Cl- Zero Cl-
NaCl 137 116.7 135 87.4
KCl 5.36 5.3 5
CaOH 3 3
CaCl2 3 3 3 3 2.625
MgCl2 0.41 0.41 0.41 0.41
HEPES 10 10 10 10 10 10 10
TEA-Cl 20 20
Glucose * 5.6 ± 5 5.6 ± 5 5.6 ± 5 5.6 ± 5 5.6 ± 5 5.6 ± 5 5.6 ± 5
NMDG-Cl** 130 135
Na-Isethionic Acid 25 135
pH to 7.4 with: NaOH NaOH NaOH KOH CH4SO3 NaOH CH4SO3
* Glucose was used to adjust osmolarity to 270 - 280. 
**1 M N-Methyl-D-glucamine-Cl stock prepared with NMDG and HCl 
Table 4.1  External Solutions (in mM)
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CaCl2 0.1 0.1 0.1
MgCl2 2 2 2
HEPES 10 10 10 10 10




pH to 7.4 with: CsOH CsOH KOH NaOH CH4SO3
Table 4.2  Internal Solutions (in mM)
 
GABA was routinely prepared as a 20 mM stock and stored at 4ºC.  Furosemide and 
Bumetanide were prepared at 300 mM stocks in DMSO.  1H-[1,2,4]Oxadiazolo[4,3-
a]quinoxalin-1-one (ODQ) was prepared at 10 mM in DMSO.  1-Hydroxy-2-oxo-3-(N-ethyl-
2-aminoethyl)-3-ethyl-1-triazene (NOC-12), 2,2'-(Hydroxynitrosohydrazino)bisethanamine 
(NOC-18), S-Nitroso-N-acetyl-D,L-penicillamine (SNAP), and 2-(4-Carboxyphenyl)-4,4,5,5-
tetramethylimidazoline-1-oxyl-3-oxide, sodium salt (Carboxy-PTIO) were obtained from 
Dojindo Molecular Technologies, Inc. (Gaithersburg, MD ) and stored at –20°C.  Solutions 
containing nitric oxide donors were prepared by dissolving the donors directly into the 
solutions.  The final pH of external solutions containing the nitric oxide donors was readjusted 
to 7.4 with NaOH (NOC 12 and SNAP) or HCl  (NOC 18).  The nitric oxide donors 
spontaneously release NO when dissolved in aqueous solutions.  The reported half lives are: 
NOC 18 (21 hours at pH 7.4 and  37°C; 57 hours at pH 7.4 and 22°C), NOC 12 (100 minutes 
at pH 7.4 and 37°C), SNAP (2 hours at pH 7.56 and 37°C).  However, it must be noted that 
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half-lives vary depending on exposure to light, temperature, and the exact composition of 
solutions.   
NO-Bubbled Solutions 
NO-bubbled solutions were prepared by first bubbling the solution with pure argon for 
15 minutes followed by 15 minutes of bubbling with pure NO.  The NO gas was first passed 
through a column of soda lime to filter out any nitric dioxide.  NO solutions were prepared 
and stored in rubber-corked 50 ml Erlenmeyer flasks.  The tightly sealed NO solutions were 
protected from light and stored at 4°C.  A 22-gauge, 1-inch syringe needle was securely 
attached to a closed two-way luer-lock valve and inserted through the rubber stopper.  NO-
bubbled solutions were removed by attaching a 1 ml syringe and then opening the valve to 
allow removal of solution.  Approximately 300 µls were removed each time.  NO solutions 
were then transferred to a 10, 25, or 50 µl Hamilton Syringe by inserting the tip of the 
Hamilton Syringe needle through the open tip of the 1 ml syringe and drawing up the desired 
volume.  The transfer process was completed within 5-10 seconds to minimize solution 
exposure with ambient air.  The NO solutions were then delivered into the perfusion system 
through in-line injections.  For cells receiving multiple injections, fresh NO solutions were 
removed from the flask before each injection.   
The elapsed time between the injection and expulsion from the perfusion barrel was 
estimated to be 2-3 seconds (measured by timing movement of dye through lines).  All of the 
injected solutions cleared the perfusion barrel within 3-5 seconds after the in-line injection 
suggesting that the NO exposure was limited to 1-3 seconds for the largest injection volumes 
with most of the NO arriving in the first 500 ms.   
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NO can dissolve in H2O at a maximum concentration of 1.9 mM, although it was 
apparent that different solutions had different concentrations of NO.  The volume injected 
ranged from 5 – 50 µl, depending on the experiment and the potency of each NO-bubbled 
solution.  Only those cells receiving the same volume of a particular NO-bubbled solution 
were used for quantitative comparisons.  The largest volume of 50 µl (NO-bubbled H2O) was 
only used during the experiment with the equal Cl- internal and external solutions (Fig. 4.8D) 
to ensure that the cells were exposed to an adequate amount of NO.     
To get an estimate of the NO concentration reaching the cells after the in-line injection 
of NO-bubbled solutions, the concentration of NO exiting the perfusion barrel was measured 
using an ISO-Nitric Oxide meter (NOMK2 system) with an ISO-NOP electrode (World 
Precision Instrument, Sarasota, FL).  The NO concentration was measured for the volume of a 
particular solution (NO-bubbled H2O) that had been effective in eliciting responses in several 
experiments.  These measurements were made with the electrode situated directly in front of 
the perfusion barrel.  The distance from the barrel to the electrode closely matched the 
distance to a cell during electrophysiology experiments.  The average NO concentration 
measured at the outlet was 2.0 +/- 0.3 µM.     
RESULTS 
Enhancement of GABA-Gated Currents by NO Donors 
 To determine if NO modulated GABA-gated currents, whole cell voltage-clamp 
recordings were made from cultured retinal amacrine cells.  For these experiments, the 
ruptured-patch configuration was used with the Cs internal and TEA external solutions.  
GABA (20 µM) was applied for 500 ms at intervals of 30 seconds.  The cells were held at –70 
mV, and application of GABA (20 µM) elicited an inward current mediated by GABAA 
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receptors (Hoffpauir and Gleason 2002).  Switching to solutions containing the NO donor, 
SNAP (500 µM), enhanced the GABA-gated currents by 15.5 ± 2.3% (Fig.  4.1 A,B).  
Experiments with lower doses of SNAP produced similar levels of enhancement suggesting 
that this effect was saturated at a concentration of 250 µM.  Including the NO-scavenger, 
Carboxy-PTIO, in the external solutions significantly reduced the SNAP-dependent 
enhancement to only 2.7 ± 2.4% (Fig. 4.1 C).  Analysis of currents in response to voltage 
ramps delivered in the presence of GABA (20 µM) revealed that the SNAP-dependent 
enhancement was not due to a shift in ECl- (Fig. 4.1 D).  Application of other nitric oxide 
donors, NOC 12 (250 µM; n = 9) and NOC 18 (300 µM; n = 12) also enhanced GABA-gated 
currents by 9.2 ± 2.1% and 12.4 ± 3.2% respectively (Fig. 4.1 E,F).  Together, these results 
indicate that NO can enhance GABA-gated currents without shifting ECl-. 
 To better evaluate the timing of the SNAP-dependent enhancement, the experimental 
protocol was altered so that GABA (20 µM) was delivered every 5 seconds for a duration of 
300 ms.  SNAP (500 µM) was applied for 50 seconds in each cell examined.  Plots of the 
peak current amplitude over time revealed that the SNAP-dependent enhancement was 
transient in nature with the peak of enhancement occurring 15 seconds after SNAP was 
applied.  After this peak, the enhancement subsided, although some degree of enhancement 
remained for the duration of SNAP exposure (Fig. 4.2).  For this subset of cells, the GABA-
gated currents were enhanced by 11.0 ± 1.8 % (n = 21) after a 15-second exposure to SNAP.  
 Nitric oxide can activate sGC and increase the intracellular concentration of cGMP.  
To determine whether the SNAP-induced enhancement was dependent upon sGC activity, 
additional voltage-clamp experiments (TEA external and Cs internal; ruptured-patch 








Figure 4.1  Nitric oxide (NO) donors enhance GABA-gated currents.  A, Peak current 
amplitudes of inward currents elicited by 500-ms applications of GABA (20 µM) are 
normalized to the current amplitude just prior to application of SNAP.  Horizontal bar 
indicates the duration of SNAP (500 µM) application.  B, Whole cell voltage-clamp 
recordings of GABA-gated currents from a representative amacrine cell recorded before 
(black trace) and in the presence of (gray trace) SNAP (500 µM).  C, The SNAP-dependent 
enhancement is reduced in the presence of the NO scavenger, Carboxy-PTIO.  Data were 
collected from the same cells and the order of application was varied.  Mean current change is 
calculated as the percent difference of GABA-gated current amplitudes measured 
immediately before SNAP application compared to those measured after 30 seconds of 
exposure to SNAP.  D, Leak-subtracted currents elicited by voltage ramps delivered in the 
presence of GABA before (black trace), and in the presence of (gray trace) SNAP (500 µM).  
Inset shows only the inward portion of GABA-gated currents during voltage ramps.  Tick 
marks are at 100 pA and 10 mV increments.  E and F, Whole cell voltage-clamp recordings 
of GABA-gated currents from representative amacrine cells.  On average, the nitric oxide 
donors, NOC 12 and NOC 18, enhanced the GABA-gated currents by 9.2 ± 2.1% (n = 9) and 




























































































































Figure 4.2  The peak of S-nitroso-N-acetyl-D,L-penicillamine (SNAP)-dependent 
enhancement occurs within 15 seconds.  A, Peak current amplitudes of inward currents 
elicited by 300-ms applications of GABA are normalized to the current amplitude just prior to 
the application of SNAP (500 µM).  GABA-gated currents are maximally enhanced by 11.0 ± 
1.8% (n = 21).  For this subset of cells, the largest enhancement observed was 30% while 5 
cells showed little or no enhancement (< 3%) in the presence of SNAP.  B, Whole cell voltage-
clamp recordings of GABA-gated currents from a representative amacrine cell before (black 
trace) and in the presence of (gray trace) SNAP.
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GABA-gated currents were recorded while the cells were exposed to SNAP in the presence or 
absence of ODQ.  The order of the SNAP and SNAP/ODQ exposure was varied from cell to 
cell.  Inhibiting sGC with ODQ (2 µM) had no effect on the SNAP-dependent enhancement 
suggesting that the SNAP-dependent enhancement of GABA-gated currents was not mediated 
by sGC (Fig. 4.3). 
NO-Bubbled Solutions Enhance GABA-Gated Currents 
 To further confirm that NO could modulate GABAergic transmission, experiments 
were run with solutions bubbled with NO.  The ruptured-patch configuration was used with 
TEA external and Cs internal solutions.  Injecting 10 µls of either NO-bubbled TEA external 
solution or NO-bubbled H2O increased the peak amplitude of GABA-gated currents by three- 
and four-fold respectively (Fig. 4.4).  In most experiments, injecting the NO-bubbled 
solutions also elicited a GABA-independent inward current, the “NO-dependent current” (Fig. 
4.4 A,C; Fig. 4.5 D).  However, enhancement occasionally occurred in the absence of this 
NO-dependent current, thus it appears that the two phenomena are not inter-dependent (see 
discussion).   
Control injections were performed to establish that the GABA-gated current 
enhancement was due to the presence of NO and not due to the acidic nature of the NO-
bubbled solutions or the brief change in osmolarity experienced by the cells upon injection of 
the NO-bubbled H2O.  In order to determine whether NO or its reaction products were 
responsible for the enhancement, the effects of air-exposed or “expired” solutions were 
examined.  The half-life of NO in an aqueous solution exposed to air is estimated to be 3-6 
seconds.  Injecting expired NO-bubbled solutions that were exposed to the ambient 
































































Figure 4.3  SNAP-dependent enhancement is insensitive to the soluble guanylate cyclase 
inhibitor, 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ).  A, Peak current 
amplitudes of inward currents elicited by 300-ms applications of GABA are normalized to the 
current amplitude just prior to SNAP (500 µM) application.  Under normal conditions, SNAP 
enhances the peak current amplitude by 17.8 ± 2.9%.  B, Whole cell voltage-clamp recordings 
of GABA-gated currents from a representative amacrine cell before (black) and in the 
presence of (gray) SNAP (500 µm).  C, Application of ODQ (2 µM) has no effect on the 
SNAP-dependent enhancement.  Data in A and C were collected from the same cells, and the 
order of ODQ application was varied.  D, Whole cell voltage-clamp recordings of GABA-
gated currents from a representative amacrine cell in the presence of ODQ before (black) and 



















Figure 4.4  Injecting solutions bubbled with NO enhances GABA-gated currents.  A, 
Injecting 10 µls of NO-bubbled TEA external enhanced GABA-gated currents.  Raw data 
shows voltage-clamp recordings of GABA-gated currents from a representative cell before 
and after injection.  Arrows indicate timing of NO injections.  Asterisk indicates NO-
dependent current observed prior to the application of GABA (see Fig 4.5).  B, Injecting 
expired NO–bubbled TEA external solutions does not enhance GABA-gated currents.  Raw 
data in A and B are from same cell.  C, Injecting 10 µls of NO-bubbled H2O enhances 
GABA-gated currents.  D, Injecting 10 µls of expired NO-bubbled H2O does not enhance 
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Additional controls performed by injecting plain H2O or acidic H2O solutions (containing 
NaOH, HCl, pH = 3) also failed to enhance the GABA-gated currents (Fig. 4.5).  Some 
inhibition of the GABA-gated currents occurred immediately after control solutions were 
injected, and a slight reduction in the holding current was also observed (Fig. 4.5 C).  For the 
expired and acidic solutions, the change in the peak current amplitude is most likely due to the 
acidic nature of the acidic and expired solutions, as low external pH (< 7.4) has been shown to 
reduce the mean open time of GABAA receptors (Huang and Dillon 1999).  For the plain H2O 
injections, the inhibition of GABA-gated currents is most likely due to a brief increase in 
resistance in the presence of the hypotonic external solution.  It should also be mentioned that 
the NO-dependent current was not observed in these control experiments, indicating that NO 
was required for both the NO-induced enhancement and the NO-dependent current. 
Enhancement of GABA-Gated Currents by NO-Bubbled Solutions Is Due to a Shift in 
ECl- 
To determine whether the enhancement was due to a shift in ECl-, voltage-clamped 
amacrine cells were held at ECl-.  In order to control ECl-, the ruptured-patch technique was 
used with the TEA external and Cs internal solutions.  After demonstrating that current was 
not produced in response to GABA, the NO-bubbled solution was injected into the perfusion 
line.  Immediately after injection, an inward GABA-gated current was observed suggesting 
that NO enhances GABA-gated currents by shifting ECl- to more positive potentials (Fig. 4.6 
A).  To quantify this shift in ECl-, voltage ramps were delivered in the presence of GABA, 
before and after injection of the NO-bubbled solutions.  On average, injecting 10 µls of the 
NO-bubbled TEA solution into the perfusion lines shifted ECl- from –56.7 ± 0.8 mV to –32.5 
± 3.8 mV (Fig. 4.6 B,C).  The average time required for recovery of ECl- to the baseline values 
(approximately 45 seconds) closely matched the time for recovery of the peak GABA-gated 
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current amplitudes after NO-bubbled solutions were injected (compare Fig. 4.4 A,C  and 4.6 
C).  Injections of expired solutions did not shift ECl- (n = 4; data not shown).  However, 
injecting the expired solutions did reduce the slope of the I-V relationship (data not shown).  
This reduction was not surprising given the previously described reduction in peak current 
amplitude for control injections (Fig. 4.5).   
Mechanism of NO-Induced Shift in ECl-  
There are three possible explanations for an apparent shift in ECl-: 1) a change in 
permeability of the GABAA receptors , 2) the introduction of another permeant ion into the 
cell, or 3) an increase in intracellular Cl-.  Besides Cl-, the other predominant anion in the Cs 
internal solution is acetate (see Table 4.2, Materials and Methods).  In order to determine if 
NO was increasing the permeability of GABAA receptors to acetate, internal acetate was 
substituted with methanesulfonate, a bulky anion unlikely to permeate the GABAA receptors.  
This substitution, however, did not prevent the NO-induced enhancement (Fig 4.7 B), 
suggesting that the NO-induced shift in ECl- was not a result of increased permeability of the 
channels to acetate. 
Nitrate is produced when NO reacts with O2 and H2O.  Unlike NO, nitrate will not 
freely diffuse across the membrane and, if it were produced after NO entered the cell, it could 
be trapped and become concentrated within the cell.  Because nitrate is permeant through 
GABAA receptors (Biscoe and Duchen 1985; Luhmann and Prince 1991), it is possible that 
trapped-nitrate is responsible for the apparent shift in ECl-.  To address this possibility, whole 
cell voltage-clamp experiments were performed with zero Cl- internal and zero Cl- external 
solutions to see whether exposure to NO would reveal a nitrate-dependent inward current 
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Figure 4.5  Changes in osmolarity or pH do not enhance GABA-gated currents.  A, Whole 
cell ruptured-patch recording of GABA-gated currents.  Injecting plain H2O slightly reduces 
the peak current amplitude of GABA-gated currents.  B, Injecting an acidic solution (pH 3.0) 
reduces GABA-gated currents.  Presumptive GABAergic minis were often observed preceding 
the onset of the GABA-gated currents after injecting acidic solutions (including NO-bubbled 
solutions) and are most likely due to acid-induced fusion of GABA-containing vesicles at 
amacrine cell autapses.  C, The leak current of an amacrine cell clamped at -70 mV decreases 
after injection of an acidic solution.  Similar changes in the holding current were also observed 
with injections of expired NO-bubbled solutions and plain H2O.  D, A 10 µl injection of NO-
bubbled H2O elicits an inward current at -70 mV.  NO-induced currents of varying sizes and 
waveform often preceded NO-induced GABA-gated current enhancement, however the 
GABA-gated current enhancement was not dependent upon the presence of the NO-dependent 















































Figure 4.6  NO shifts ECl- to more positive potentials.  A, Ruptured-patch voltage-clamp 
recordings of an amacrine cell held at ECl-.  GABA is applied for 300 ms during each trace.  
No GABA-gated currents are observed until injection of 10 µls of NO-bubbled H2O (arrow).  
Asterisk denotes NO-dependent current.  B, Voltage ramps in the presence of GABA (20 µM) 
were delivered before (black trace) and after (gray trace) injection of 10 µls of NO-bubbled 
TEA external.  C, Average ECl- values for 8 cells exposed to NO-bubbled TEA external 
solutions.  Current traces in B and data used in C were leak-subtracted and corrected for 
junction potential errors.
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currents were observed either before or after injection of NO-bubbled H2O (Fig. 4.7 A).  This 
observation argues against the possibility that the current enhancement was due to an increase 
in intracellular nitrate. 
The third possibility was that Cl- redistribution (influx) was driving the change in ECl-.  
To address this possibility, experiments were performed in solutions with equal Cl- 
concentrations inside and outside of the cell.  For these experiments, relatively large volumes 
(50 µls) of NO-bubbled H2O were injected to ensure that a sufficient amount of NO was 
reaching the cells.  Eliminating the Cl- gradient abolished the NO-induced shift in ECl- (Fig. 
4.7 C), although the NO-dependent current was still observed.  A decrease in the slope of the 
I-V relationship was observed after the injection.  A similar decrease in current amplitude was 
also observed when expired NO solutions or acidic solutions were injected in control 
experiments, suggesting that this apparent change in conductance was a result of the low pH.  
Together, these data support the hypothesis that the NO-induced shift in ECl- is due to an 
increase in intracellular Cl-.      
Amacrine Cells Express KCC2 and NKCC: Two Mechanisms that Regulate [Cl-]i 
 The Na+-K+-Cl- cotransporter (NKCC) and the K+-Cl- cotransporter (KCC) represent 
two Cl- cotransport mechanisms that regulate the internal Cl- concentration.  In most cells, 
NKCC transports Cl-, Na+, and K+ at a stoichiometry of 2 Cl-, 1 Na+, and 1 K+.  However, a 
stoichiometry of 3Cl-, 2Na+, and 1K+ has been reported in the squid giant axon (for review, 
see Russell 2000).  The neuron specific K+-Cl- cotransporter, KCC2, typically transports 1 Cl- 
and 1 K+ out of the cell.  However, the direction of KCC2 transport is dependent upon the K+ 
and Cl- concentrations, and KCC2-mediated influx has been observed (DeFazio et al. 2000; 























































Figure 4.7  The apparent shift in ECl- is likely due to an increase in intracellular Cl-.  A, 
Ruptured-patch voltage-clamp recordings of an amacrine cell held at -70 mV.  Internal and 
external solutions both lack Cl-.  GABA is applied for 300 ms in each trace.  Time scale bar 
applies only to current traces (start to start intervals are 10 seconds for this cell).  Arrow 
denotes injection of 25 µls of NO-bubbled H2O.  An NO-dependent current was recorded 
immediately after the injection (data not shown).  B, Substituting methane-sulfonate for 
acetate in the Cs internal solution does not prevent NO-induced enhancement.  Arrows denote 
injection of 10 µls of NO-bubbled H2O.  The NO-dependent current (asterisk) is also observed 
with these solutions.  C, Ruptured-patch recordings before (black trace) and after (gray trace) 
injection of NO-bubbled H2O in zero Cl- external and internal solutions.  Eliminating the Cl- 
gradient reduces the NO-induced shift in ECl- (mean shift in ECl- = 0.5 ± 0.2 mV, n=5) .  The 
slope of the I-V relation was reduced in all cells examined, a finding consistent with injections 
of expired NO-bubbled solutions or acid with Cs internal and TEA external solutions (data not 
shown).
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influences the distribution of Cl-.  Both of these transporters are considered electrically silent 
in that their activities do not alter the membrane potential nor does the membrane potential 
affect their function.  The shift to more positive ECl- by NO could be due to activation of 
NKCC or KCC2-mediated Cl- influx or the inactivation of KCC2-mediated Cl- efflux.    
To determine whether amacrine cells express NKCC or KCC2, double labeling 
experiments with antibodies raised against NKCC (monoclonal) and KCC2 (polyclonal) were 
performed on frozen sections of the adult chicken retina.  NKCC labeling was present in all 
layers of the retina (Fig. 4.8 A).  Amacrine cell bodies are primarily located in the inner one-
third of the inner nuclear layer (INL) and in the ganglion cell layer (GCL).  In the INL, 
labeling of somata was not confined to the plasma membrane (for comparison see KCC2 
labeling pattern in INL) indicating that a significant fraction of NKCC is intracellular.  NKCC 
was highly expressed in the inner plexiform layer (IPL) where amacrine cells extend their 
processes and form synapses.  KCC2 was also expressed in both the INL and IPL (Fig. 4.8 B).  
Unlike NKCC, KCC2 expression appeared to be concentrated at the cell surface of somata in 
the INL.  Expression of KCC2 within the IPL, like that of NKCC, was also abundant.  A 
similar expression pattern for KCC2 has previously been reported in the rat retina (Vu et al. 
2000).  Overlays of images like those shown in Figure 4.8 (A,B) confirm that NKCC and 
KCC2 are co-expressed and that their expression pattern is consistent with expression by 
amacrine cells as well as other cell types in the adult chicken retina. 
Immunocytochemistry experiments with the same primary antibodies confirmed that 
NKCC and KCC2 are co-expressed in cultured GABAergic amacrine cells.  As in the intact 
retina, both cotransporters appear to be expressed at high levels in cultured cells that were 
fixed on PE1 (Fig 4.9 A,B).  Also consistent with the labeling pattern found in sections, 
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KCC2 expression is prominent on the cell surface of amacrine cell bodies while NKCC is 
more prevalent intracellularly in this region of the cell.  Distinct hot spots of KCC2 labeling 
can be observed throughout the processes as previously observed in the characterization of the 
KCC2 antibody (Williams et al. 1999).  For double-labeled cells (Fig. 4.9 C), spots of co-
expression were often found out in the processes.   
It has been demonstrated in several systems that levels of NKCC expression often 
decline with development (Plotkin et al. 1997; Kakazu et al. 1999; Lu et al. 1999).  Consistent 
with this, cultures fixed at EE 13 were much more heavily labeled with the NKCC antibody 
than were cultures fixed on PE 1 (data not shown).  However, results from the adult chicken 
retina and the older retinal cultures indicate that both KCC2 and NKCC are co-expressed in 
the cell bodies and processes of adult GABAergic amacrine cells.   
Cl- Cotransport Influences the Cl- Distribution in GABAergic Amacrine Cells but Is not 
Involved in the NO-Induced Shift in ECl- 
  
 To determine whether NKCC or KCC2 were involved in establishing ECl- in cultured 
GABAergic amacrine cells, perforated-patch voltage-clamp recordings were made with 
gramicidin.  Gramicidin was selected because it provides electrical access through Cl- 
impermeable pores.  Thus, unlike ruptured-patch recordings, this configuration prevents the 
artificial redistribution of Cl- caused by diffusion of the internal solution from the pipette into 
the cell.  When cells were voltage-clamped at –70mV in control conditions (normal external 
and internal containing gramicidin), applying GABA (20 µM) produced an inward current.  
Application of GABA at intervals shorter than 30 seconds progressively moved ECl- to more 
negative potentials presumably because the cellular processes responsible for maintaining ECl-  














Figure 4.8  The Cl- cotransporters NKCC and KCC2 are expressed by amacrine cells in 
the retina.  A, Anti-NKCC labeling is found in both the cellular layers (photoreceptor (PR), 
inner nuclear layer (INL) and ganglion cell layer (GCL)) and synaptic layers (outer plexiform 
layer (OPL) and inner plexiform layer (IPL)) of the chicken retina.  Ganglion cell axons are 
also labeled (below GCL).  Labeling in the INL where amacrine cells reside (lower one-third) 
is diffuse, suggesting that at cell bodies, a significant fraction of this transporter is 
intracellular.  B, Anti-KCC2 labeling in the same retinal section as shown in A or this 
transporter, expression is largely confined to the OPL, the INL, the IPL and a subset of cell 
bodies in the GCL.  The labeling pattern in the INL is consistent with primarily surface 
expression of this transporter for INL cell bodies.  C, Overlay of A and B.  Regions appearing 
yellow indicate overlap of the labels.  Notably, NKCC and KCC are co-expressed in the INL 
where amacrine cell bodies are located and in the IPL, where amacrine cells extend their 
processes.  D, Control experiment for NKCC.  No labeling was detected after pre-incubation 
with NS1 (supernatant of the fusion partner cell line) at a dilution of 1:10 followed by 
incubation with the Alexa-488 goat anti-mouse secondary.  E, The Cy3-conjugated goat anti-




determined that a stable ECl- could be achieved with 30-second intervals, although some shift 
occurred during the first several recordings.       
 To block NKCC and KCC2 activity, the cotransport inhibitors, bumetanide and 
furosemide were applied to the cells.  Bumetanide primarily inhibits NKCC, although it can 
also reduce KCC2 activity (Russell 2000).  Furosemide is considered a specific inhibitor of 
KCC2 that can also inhibit NKCC at higher concentrations (Payne 1997).  In these 
experiments, inhibitor concentrations were used that would reduce both processes.  After a 
steady ECl- was established, switching to solutions containing either bumetanide (300 µM) or 
furosemide (300 µM) shifted ECl- to more negative values (Fig. 4.10 A,B).  Overall, 
furosemide had a greater effect (shift in ECl- = -11.0  ± 0.9 mV, n = 9) on the resting ECl- than 
bumetanide (shift in ECl- = -2.7 ± 3.1 mV, n = 5).  The shift to more negative potentials was 
consistent with a dominant effect on NKCC or KCC2 influx.   
To determine whether the cotransporter inhibitors could prevent the NO-induced shift 
in ECl-, injections of NO-bubbled solutions were made in the presence and absence of 
inhibitors.  When the NO-induced shifts in ECl- were compared, it was observed that neither 
cotransporter inhibitor significantly reduced the NO-induced shift in ECl- (Fig. 4.10).  
Although there was a non-significant reduction of the shift in ECl- in the presence of 
furosemide (p = 0.0618, two-tailed paired t-test), several cells showed little or no difference 
between NO-induced shifts in furosemide when compared to control injections.  Therefore, it 
appeared that the inhibitors for NKCC and KCC2 did not inhibit the NO-induced shift in ECl-.     
Removing Ions Required for Cotransport Does not Block the NO-Induced Shift in ECl-
 To further examine the possibility that the shift in ECl- is due to activity of NKCC or 
























































































Figure 4.10  Bumetanide and furosemide do not prevent NO-induced shift of ECl-.  A and 
B, Perforated-patch voltage-clamp records with gramicidin.  Voltage ramps were delivered in 
the presence of GABA under control conditions (1), in the presence of inhibitor (2), and after 
injection of 25 µls of NO-bubbled H2O into bumetanide or furosemide containing solutions 
(3, gray trace).  C and D, Cl- co-transporter inhibitors do not significantly reduce NO-
induced shift in ECl-.  NO-induced shifts in ECl- in the presence of each inhibitor were 
compared to control injections of NO-bubbled solutions with the same cells.
85
Three separate external solutions were prepared with zero K+ and/or zero Na+ (see Table 4.1, 
Materials and Methods).  Thermodynamic models indicate that the direction of Cl- cotransport 
through KCC2 is primarily dependent upon the K+ gradient (Payne 1997; Kakazu et al. 2000).  
Conversely, the Na+ and Cl- gradients drive NKCC activity, although the presence of K+ is 
required for activity (Russell 2000).  Thus, it is predicted that application of external solutions 
with zero Na+ will inhibit NKCC activity with no direct effect on KCC2.  Alternatively, 
application of external solutions lacking K+ should prevent activity of NKCC and increase the 
outward Cl- flux through KCC2 as a result of the increased outward K+ gradient.   
For these experiments, the cells were voltage-clamped using the perforated-patch 
technique with gramicidin in the normal internal solution.  As expected, switching from 
normal solutions to those lacking the required cotransported ions shifted ECl- to more negative 
potentials.  Furthermore, for those cells that were exposed to both zero K+ and zero Na+ 
solutions, ECl- was noticeably more negative in zero K+ solutions than in zero Na+ solutions 
(Fig. 4.11 A).  In some cases, switching to zero K+ shifted ECl- by tens of mVs in as few as 15 
seconds (Fig. 4.11 B).  These results were consistent with the hypothesis that zero external K+ 
would both prevent inward Cl- transport through NKCC and promote outward Cl- transport 
through KCC2.  However, the NO-induced shift in ECl- was still observed in all of the 
solutions lacking the required cotransported ions (Fig. 4.11 C-F).  These results indicate that 
the NO-induced shift in ECl- is not dependent upon the presence of external Na+ or K+.  This  
implies that either the NKCC and KCC2 cotransporters are not involved or, if they are, they 















Figure 4.11  Ionic dependence of NO-induced shift in ECl-.  A-E, Perforated patch voltage-
clamp recordings made with gramicidin.  Voltage ramps were delivered in the presence of 
GABA for each condition.  A, ECl- is negatively shifted in solutions lacking K+ or Na+.  The 
shift from normal solutions (1) was greater in solutions with zero external K+ (2) than in 
solutions with zero external Na+ (3).  B, Switching from normal (1) to zero K+ external 
solutions (2) can produce large negative shifts in ECl-.  Dotted gray line shows extrapolated 
ECl- in zero external K+.  Zero K+ external solution was applied 15 seconds before trace 2. C-
E, Bathing the cells in zero Na+, zero K+, or zero Na+ and K+ external solutions did not 
prevent the NO-induced shift in ECl- (gray traces).  F, Average NO-induced shifts in ECl- for 
cells bathed in zero Na+ or zero K+ external solutions (n = 5).   
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GABA Depolarizes Amacrine Cells after NO Injection 
 GABA is generally considered to be an inhibitory neurotransmitter.  However, the 
direction of the Cl- flux through GABAA receptors depends upon the relative concentrations 
of Cl- that are responsible for setting ECl-.  To determine what effect the NO-induced shift in 
ECl- would have on GABA-dependent changes in membrane potentials, isolated amacrine 
cells were examined in the current-clamp mode using the ruptured-patch configuration with 
normal internal and external solutions.  Membrane potentials were recorded as the cells were 
exposed to GABA before and after NO-solution injections.  For the seven cells in this 
experiment, the resting membrane potential varied from –45 mV to –80 mV.  Under normal 
conditions, four of the cells had resting membrane potentials more negative than ECl-, thus 
application of GABA (20 µM) depolarized these cells.  GABA hyperpolarized the three cells 
with more positive resting potentials.  The average membrane potential recorded in the 
presence of GABA under control conditions was –58.9 ± 5.1 mV.  After injection of the NO 
solution, a transient depolarization in the membrane potential was observed that was most 
likely due to activation of the NO-dependent current observed in voltage-clamp experiments 
(Fig. 4.12 B).  When GABA was subsequently applied, all of the cells were depolarized, and 
the average GABA-dependent membrane potential increased by 13.7 mV to –44.9 ± 8.1 mV 
(Fig. 4.12).   
DISCUSSION  
These results indicate that NO can modulate GABAergic signaling in cultured retinal 

























































Figure 4.12  GABA can depolarize amacrine cells after exposure to NO-bubbled 
solutions.  A, Whole cell current-clamp recordings from an isolated amacrine cell in culture.  
Ruptured-patch recording technique was used with the normal external and internal 
solutions.  With zero current injected, GABA (20 µM) hyperpolarizes the cell under control 
conditions (black trace).  After injection of 10 µls of NO-bubbled H2O, GABA depolarizes 
the cell (gray trace).  B, Whole cell current-clamp recording from cell shown in A.  Injection 
of NO-bubbled H2O (arrow) produces a transient depolarization presumably due to the 
activation of the NO-dependent inward current.  C, On average, injecting NO-bubbled 
solutions increases the membrane potential in the presence of GABA from -58.9 ± 5.1 mV to 
-44.9 ± 8.1 mV.  Data shown in A, B, and data compiled in C were corrected for junction 
potential errors.
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lower concentrations of NO can modulate GABAA receptors and enhance GABA-gated 
currents.  This effect involves no change in ECl- and is independent of sGC activity.  Applying 
higher concentrations of NO (pulses of NO-bubbled solutions) produces an apparent increase 
in intracellular Cl- and shifts ECl- to more positive potentials.  Thus, NO can convert the role 
of GABA from inhibition to excitation; functionally modulating the sign of signaling between 
GABAergic amacrine cells in the IPL.         
NO Alters the Functional Properties of GABAA Receptors 
The GABA-gated current enhancement in the presence of SNAP suggests that NO can 
modulate the functional properties of GABAA receptors or GABAA receptor-associated 
proteins.  The SNAP-dependent increase in the slope of the I-V relationship can be explained 
by 1) an increase in the receptors’ sensitivity to GABA, 2) an increase in the mean open time 
of the channels, or 3) an increase in GABAA receptor channel conductance.  The first two 
mechanisms are best addressed by single channel recordings, and thus beyond the scope of the 
present study.  It is possible to get a measure of receptor sensitivity based on dose-response 
curves.  However, results from previous dose-response experiments (see chapter 3) revealed 
significant receptor desensitization at higher GABA concentrations ( ≥ 50 µM).  Given the 
long intervals between GABA applications that were required to minimize the desensitization 
and the transient nature of the SNAP dependent enhancement, it became apparent that such an 
experiment was not feasible.  Thus, the precise mechanism for the SNAP-dependent 
enhancement remains unknown.             
Inhibiting sGC activity with ODQ did not prevent the SNAP-dependent enhancement, 
suggesting that these effects are not mediated by the NO/cGMP pathway.  One possible 
explanation is that NO might be directly interacting with GABAA receptor subunits.  Previous 
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reports indicate that NO released from the nitric oxide donor, NOC 18, inhibits GABA-gated 
currents by directly interacting with γ2S subunit of recombinant GABAA receptors expressed 
in Xenopus oocytes (Fukami et al. 1998).  Alternatively, the NO-donor effect could also be 
due to S-nitrosylation of the GABAA subunits.  Several neuronal targets of S-nitrosylation 
have already been identified including voltage-gated and ligand-gated ion channels (for 
review, see Ahern et al. 2002).  Although S-nitrosylation of GABAA receptors has not yet 
been demonstrated, it is plausible that these receptors could also be modulated by S-
nitrosylation.   
Several GABAA receptor-associated proteins have been previously isolated (Sassoe-
Pognetto et al. 1995; Kannenberg et al. 1997; Moss and Smart 2001).  Many proteins, such as 
gephryn and the GABAA-receptor associated protein are believed to function in receptor 
targeting or coupling to other proteins in postsynaptic signaling complexes.  However, little is 
known about how these and other associated proteins affect GABAA receptor function.  It is 
also possible that S-nitrosylation or a direct interaction with NO might affect these receptor-
associated proteins and lead to changes in the function of GABAA receptors. 
It should be noted that although the results presented here fail to link the NO donor-
dependent enhancement of GABA-gated currents to sGC activity, a previous study using 
cultured rat amacrine cells demonstrated inhibition of GABA-gated currents through a 
NO/cGMP-dependent pathway (Wexler et al. 1998).  The differences between these studies 
could be attributed to the great diversity of GABAA receptor subunits.  There are currently 18 
known subunits (α1-6, β1-4, γ1-4, ε, δ, θ, and π) that can potentially form thousands of 
unique pentameric GABAA receptors (for review, see Hevers and Lüddens 1998; Cherubini 
and Conti 2001).  An additional factor may be that the GABAA subunits, β4 and γ4, are only 
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expressed in chicken (Bateson et al. 1991; Harvey et al. 1993), and little is known about how 
these subunits affect the physiology of functional GABAA receptors.  Clearly, more 
information on how the receptor subunits work together will be beneficial in understanding 
how GABAA receptors are regulated.   
The NO-Dependent Current 
The functional characteristics of the NO-dependent current remain unknown.  
Although it was not always observed in cases of NO-induced enhancement, GABA-gated 
currents were enhanced in virtually every case where the NO-dependent current was 
produced.  The only exception occurred with the experiments involving zero Cl- internal and 
external solutions.  In those cases, the NO-dependent current was produced although no 
GABA-gated currents were detected before or after the injection, indicating that this current is 
not dependent on a Cl- flux.  Additional support for this hypothesis was obtained during 
experiments where cells were continuously bathed in GABA.  When, NO-bubbled solutions 
were injected into the GABA-containing solution lines, a sharp inward current (matching the 
waveform of the NO-dependent current) was recorded that quickly recovered before a slower 
and longer lasting enhancement of the GABA-gated current (data not shown).  The 
appearance of the assumed NO-dependent current before the enhancement of the GABA-
gated current further indicates that the NO-dependent current is independent of the Cl- influx 
and that the NO-dependent current actually occurs before the shift in ECl-.     
NO has been reported to release Ca2+ from intracellular stores in aortic smooth muscle 
cells (Hirakawa et al. 1999), Schaffer collateral cells in the hippocampus (Reyes-Harde et al. 
1999), and parotid acinar cells of the mouse and rat (Watson et al. 1999; Looms et al. 2001).  
Therefore, it is possible that the NO-dependent current is produced by some Ca2+-dependent 
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mechanism.  However, this seems unlikely because including the fast Ca2+ chelator, BAPTA 
(10 mM) in the recording pipette during ruptured-patch experiments did not prevent the NO-
dependent current nor did it prevent the NO-induced enhancement of GABA-gated currents 
(data not shown).  A recent study reported a NO-dependent Ca2+ influx pathway involved in 
refilling calcium stores in cultured astrocytes (Li et al. 2003).  In the experiments described 
here, all external solutions contained Ca2+, however it is unlikely that such a mechanism is 
responsible for the NO-dependent current because including the general Ca2+ channel blocker, 
LaCl3, in the external solutions failed to prevent the NO-dependent current.  Because NO can 
activate sGC and increase cGMP levels, it is possible that cyclic nucleotide- gated channels 
(CNGs) are present and activated upon injection of NO-bubbled solutions. However, no 
inward currents were recorded when cells were exposed to nitric oxide donors or 8-Br-cGMP 
(1 mM).  Therefore, if these currents are a result of CNG activation, it would appear that only 
higher NO concentrations (as achieved with NO-bubbled solutions) are capable of producing 
enough cGMP to activate these channels.    
Different Effects of NO Donors and NO-Bubbled Solutions 
It was previously demonstrated that NO can inhibit glutamate release through two 
different signaling pathways at rat hippocampal synapses (Sequeira et al. 1999).  Low levels 
of NO inhibited glutamate release through a PKG-dependent pathway, while high 
concentrations of NO prevented release through an unknown PKG-independent pathway.  It 
was suggested that different intracellular signaling pathways possess different sensitivities to 
NO.  The results presented here indicate that in amacrine cells NO can modulate GABAergic 
signaling through two distinct mechanisms, by altering receptor function and shifting ECl-.  In 
this case it would appear that the mechanism responsible for the donor-dependent 
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enhancement (at lower NO concentrations) is more sensitive to NO than the signaling 
mechanism responsible for the shift in ECl-. 
Regulation of ECl- in Amacrine Cells 
NKCC and KCC cotransporters are part of a cation-chloride cotransporter superfamily 
that also includes the Na+-Cl- cotransporters (NCC).  The four members of the KCC family 
(KCC1-KCC4) are closely related (approximately 70% sequence similarity), and share the 
same structure of 12 transmembrane domains with their C and N terminals in the cytosol.  The 
neuron specific KCC2 is of particular interest during neuronal maturation due to its central 
role in establishing the inward Cl- gradient that allows GABA to hyperpolarize mature 
neurons (Rivera et al. 1999; Ganguly et al. 2001).  The direction of cotransport through KCC2 
is reversible and dependent upon the K+ gradient.  In fact, a previous study has shown that 
replacing K+ with Cs+ in the recording pipette reverses the direction of KCC2 mediated Cl- 
cotransport (Kakazu et al. 2000).  Although it has been shown that NO can activate Cl- 
cotransport in vascular smooth muscle cells and sheep red blood cells through a PKG-
dependent pathway (Adragna et al. 2000; Adragna et al. 2002), the results presented here, 
suggest that Cl- influx through KCC2 is not responsible for the NO-induced shift in ECl- 
because this effect was still observed when 1) recordings were made in conditions promoting 
Cl- efflux (internal solutions with high concentrations of K+), 2) cells were bathed in high 
concentrations of the KCC2 inhibitor, furosemide, and 3) cells were bathed in solutions 
lacking the required cotransported cation, K+.   
As previously stated, nitrate is one of the metabolic end products of NO, and an apparent shift 
in ECl- would be expected if nitrate were to become trapped inside the cell.  In addition to 
nitrate production within the cell, it is also possible that nitrate that is produced outside of the 
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cell might be transported into the cell.  Although it appears that nitrate can be transported by 
KCC2 (Armsby et al. 1995) and NKCC (Brown and Murer 1985; Kinne et al. 1986; Turner et 
al. 1986; Russell 2000), the results obtained with zero and equal Cl- solutions argue against 
nitrate influx through these cotransporters.  Therefore, although these results fail to pinpoint 
the mechanism, it does appear that Cl- redistribution is responsible for the NO-induced shift in 
ECl-.   
The dramatic changes in ECl- further underscore the importance of Cl- cotransport in 
modulating GABAergic signaling between amacrine cells.  The average NO-induced shift in 
ECl- of approximately +20 mV observed during the ruptured-patch recordings would imply 
that the intracellular Cl- concentration doubled, from 14 to 28 mM.  At first, a mechanism 
capable of producing such a large Cl- influx is difficult to imagine.  However, the large and 
fast negative shifts in ECl- observed when cells were exposed to solutions lacking K+ make the 
case that large and rapid changes in internal Cl- concentrations can occur.  In fact, the 
observed shifts were of sufficient size to reverse the polarity of the GABA-gated currents (Fig 
4.11 B), and internal Cl- concentrations were reduced by as much as 70% after a 15 second 
exposure (12.6 mM to 3.9 mM, based on calculations from ECl- values shown in Fig. 4.11 B).  
As with the NO-induced shift in ECl-, these negative shifts in ECl- were electrically silent, 
suggesting that the effect was due to Cl- cotransport mechanisms and not a result of activating 
Cl- channels.  Additional support for the extreme efficiency of Cl- cotransport mechanisms 
comes from a study using the ratiometric Cl- indicator, Chlomeleon (Kuner and Augustine 
2000).  In that study, it was found that GABA-gated currents ranging from 0.1 to 2 nA 
increased intracellular Cl- by 10-90 mM in cultured hippocampal neurons.  Although the 
GABA-dependent increase in Cl- concentration alone is impressive, the cell’s ability to 
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recover to baseline Cl- concentrations within 15-20 seconds would suggest that Cl--
cotransport mechanisms routinely move large quantities of Cl- across the membrane.  
Together, these results support the hypothesis that an as yet unidentified NO-sensitive Cl- 
transport mechanism is responsible for the NO-induced shift in ECl-.    
Functional Significance 
How might these mechanisms affect GABAergic signaling between amacrine cells in 
the IPL of the retina?  The extreme diversity of synaptic partners and complex synaptic 
arrangements of GABAergic amacrine cells in the IPL (Dowling and Boycott 1965; Kolb 
1997; Hartveit 1999; Marc and Liu 2000) complicate this issue.  However, if one focuses 
solely on reciprocal synaptic interactions between two GABAergic amacrine cells, an 
interesting hypothesis emerges (Figure 4.13).  If only one cell receives glutamatergic input 
from a pre-synaptic bipolar cell, then increasing calcium levels might trigger NO production.  
Functional imaging of NO production in the turtle retina suggests that amacrine cells retain 
the vast majority of NO that they produce in their somata and synaptic boutons (Blute et al. 
2000).  Although it is clear that NO does freely diffuse throughout the IPL (Blute et al. 2003), 
this apparent retention or diffusion limit creates regions of high and low NO inside and 
outside of the cell, respectively.  It is therefore possible that signaling at GABAergic synapses 
formed by the NO-producing cell could be enhanced by direct modulation of the post-synaptic 
GABAA receptors by low levels of diffusing NO.  The effect of this modulation would be an 
increase in GABA-dependent inhibition, the putative effect of GABA in the IPL.  Inside the 
NO-producing cell, where the NO-concentration is higher, a shift in ECl- might occur.  
Depending on the extent of ECl- shift, GABAergic inputs that previously served as inhibitory 
signals would be reduced in amplitude or possibly reversed to produce depolarizations.   
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Figure 4.13  A model of the effect of NO in the IPL.  A, Reciprocal synapses between two 
GABAergic amacrine cells.  GABA release by both cells produces a post-synaptic membrane 
hyperpolarization in the other.  B, If one cell receives a large Ca2+ signal, nNOS can be 
activated, leading to the production of NO.  High concentrations of NO activate a NO-
dependent Cl- transporter, increasing [Cl-]i in the NO-producing cell.  If the NO-induced shift 
in ECl- is large enough, GABA from neighboring cells can depolarize the NO-producing cell.  
Diffusion of a lower concentration of NO affects post-synaptic GABAA receptors and enhances 
inhibitory GABA-gated currents resulting in less GABA release.  Overall, this mechanism 




Overall, this process would strengthen any GABAergic signal from the NO-producing cell to 
the post-synaptic cell while diminishing any inhibitory effects of GABAergic inputs onto the 
NO-producing cell.  In this scenario, NO might serve as a powerful and relatively rapid 
mechanism to amplify the signal from a particular GABAergic amacrine cell to another. 
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 Improvements in imaging techniques have steadily advanced the field of visual 
neuroscience as more data pertaining to retinal anatomy is revealed.  Although function is 
often inferred from form, knowing only the pre- and post-synaptic partners and the 
transmitters at a synapse fails to tell the whole story.  The existence of the signal 
transduction infrastructure has long suggested that certain modulatory events were likely 
at work in the retina.  However, teasing out the details has been complicated due to the 
complex architecture of the retina, especially in the inner plexiform layer (IPL).     
Glutamate release from activated bipolar cells can mediate excitatory fast synaptic 
transmission by activating ionotropic glutamate receptors, some of which are Ca2+-
permeant.  Glutamate also has the potential to increase Ca2+ levels by activating group I 
metabotropic glutamate receptors (mGluRs).  A recurring theme throughout this work is 
the importance and interconnection of glutamate and Ca2+.  Based on the results 
presented here, it appears that GABAergic signaling between amacrine cells can be 
modulated, both by the activation of mGluR5 and by the Ca2+-dependent production of 
nitric oxide.  Clearly the mechanisms are different, and additional work is required to 
determine where and when such modulatory mechanisms might be utilized in the intact 
retina.  Nonetheless, these results support the hypothesis that signaling between 
GABAergic amacrine cells can be modulated, and that this modulation can play a 
prominent role in processing the visual signal in the IPL of the retina.    
In chapter 1, we described a novel mGluR5 splice variant.  This variant has a 
truncated C-terminal tail, and it is the shortest mGluR5 described to date.  Whether this 
receptor is functionally expressed, remains unknown.  However, sequence analysis of this 
truncated receptor suggests that chicken mGluR5 can couple to multiple G-proteins, 
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creating some diversity in the physiological response of mGluR5 activation.  One 
signaling pathway initiated by activated mGluR5 occurs via the IP3 pathway, and the 
subsequent activation of the Ca2+-dependent protein kinase.  The results presented in 
chapter 3 indicate that signaling through this pathway can enhance GABA-gated currents.   
Another Ca2+-dependent signaling pathway present in the IPL involves the 
production of NO.  In chapter 4, we described how NO can modulate GABAergic 
signaling through two distinct mechanisms.  Lower concentrations of NO appear to be 
sufficient to initiate a cGMP-independent process that enhances GABA-gated currents by 
directly affecting the functional properties of GABAA receptors.   Often, it is assumed 
that modulating synaptic transmission is limited to changes in the function or expression 
of receptors, or to changes in the efficacy of pre-synaptic transmitter release.  However, 
the NO-induced shifts in ECl- shown in chapter 4 emphasize the powerful modulatory 
effects of altering internal ion concentrations.  Furthermore, it suggests that these 
processes can lead to quick changes in post-synaptic responses to inhibitory 
neurotransmitters, and possibly convert an inhibitory synapse into an excitatory synapse.  
Clearly, these Cl- cotransport mechanisms that were once considered mere housekeeping 
functionaries are in fact dynamic and powerful regulators of cell function.  Thus, the 
scope of modulatory mechanisms is expanding, and it will be interesting to see what lies 
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